WO2016008883A1 - Biosynthesis of monoterpenes in cyanobacteria - Google Patents

Biosynthesis of monoterpenes in cyanobacteria Download PDF

Info

Publication number
WO2016008883A1
WO2016008883A1 PCT/EP2015/066061 EP2015066061W WO2016008883A1 WO 2016008883 A1 WO2016008883 A1 WO 2016008883A1 EP 2015066061 W EP2015066061 W EP 2015066061W WO 2016008883 A1 WO2016008883 A1 WO 2016008883A1
Authority
WO
WIPO (PCT)
Prior art keywords
seq
monoterpene
cyanobacterial cell
cell according
functional enzyme
Prior art date
Application number
PCT/EP2015/066061
Other languages
French (fr)
Inventor
Vinod PUTHAN VEETIL
Klaas Jan Hellingwerf
Original Assignee
Photanol B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photanol B.V. filed Critical Photanol B.V.
Publication of WO2016008883A1 publication Critical patent/WO2016008883A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1085Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88Lyases (4.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P15/00Preparation of compounds containing at least three condensed carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02Oxygen as only ring hetero atoms
    • C12P17/06Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P5/00Preparation of hydrocarbons or halogenated hydrocarbons
    • C12P5/007Preparation of hydrocarbons or halogenated hydrocarbons containing one or more isoprene units, i.e. terpenes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/02Preparation of oxygen-containing organic compounds containing a hydroxy group
    • C12P7/04Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26Ketones
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00Preparation of oxygen-containing organic compounds
    • C12P7/24Preparation of oxygen-containing organic compounds containing a carbonyl group
    • C12P7/26Ketones
    • C12P7/38Cyclopentanone- or cyclopentadione-containing products
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y205/00Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
    • C12Y205/01Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
    • C12Y205/01001Dimethylallyltranstransferase (2.5.1.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y402/00Carbon-oxygen lyases (4.2)
    • C12Y402/03Carbon-oxygen lyases (4.2) acting on phosphates (4.2.3)
    • C12Y402/03016(4S)-Limonene synthase (4.2.3.16)

Definitions

  • the present invention relates to a process for producing a monoterpene and to a cyanobacterial cell for the production of a monoterpene.
  • Isoprenoids are comprised of diverse group of molecules found in all organisms, where they carry out important biological functions. For example, as quinones in electron transport, as components of membranes (prenyl-lipids in archaebacteria, sterols in eukaryotes), in subcellular targeting (prenylation of proteins), in hormone signaling in mammals (steroids), as photosynthetic pigments (carotenoids) and as semiochemical secondary metabolites in plants (monoterpenes, sesquiterpenes, diterpenes). They are the most abundant and structurally diverse natural products with more than 55,000 identified in bacteria, archaea and eukaryotes. Some are also commercially important as pharmaceutical ingredients, flavors, fragrances, cosmetic ingredients and also have been explored as precursors to alternative fuel.
  • U.S. Pat. No. 6,699,696 describes a process of producing ethanol by feeding carbon dioxide to a cyanobacterial cell, especially a Synechococcus comprising a nucleic acid molecule encoding an enzyme enabling the cell to convert pyruvate into ethanol, subjecting said cyanobacterial cell to sun energy and collecting ethanol.
  • This system has several drawbacks among others the expression system used is temperature sensitive which demands to adapt the production system for such regulation.
  • WO 2009/078712 describes a process of producing ethanol, propanol, butanol, acetone, 1,3- propanediol, ethylene or D-lactate and where appropriate intermediary compounds in the pathway leading to any of these organic compounds.
  • the process is carried out by feeding carbon dioxide to a culture of cyanobacterial cells and subjecting the culture to light, wherein the cells are capable of expressing a nucleic acid molecule under the control of a regulatory system which responds to a change in the concentration of a nutrient in the culture which confers on the cell the ability to convert a glycolytic intermediate into the above-mentioned organic compounds and/or into intermediary compounds.
  • isoprenoids are derived from five-carbon isoprene units and are synthesized from two universal C5 building blocks: isopentenyl diphosphate (IPP) and its isomer dimethylallyl diphosphate (DMAPP), which in turn can be produced by two distinct well studied routes: the mevalonate (MVA) pathway (see Figure 1) or the l-deoxy-D-xylulose-5-phosphate (DXB) pathway (the DXB pathway is also referred to as the MEP pathway based on another intermediate "2-C-methyl-D-erythritol-4-phosphate”); see Figure 2. Both pathways are distributed throughout nature.
  • MVA mevalonate
  • DXB l-deoxy-D-xylulose-5-phosphate
  • DXB pathway is also referred to as the MEP pathway based on another intermediate "2-C-methyl-D-erythritol-4-phosphate”
  • the MVA pathway is present in all eukaryotes (mammals, fungi etc.) and all archaea. Some Gram positive bacteria like Staphylococcus, Streptococcus, Enterococcus, Lactococcus, Lactobacillus, and Leuconostoc, and some Gram negative bacteria like Myxobacteria, also use the MVA pathway, whereas most other bacteria, including cyanobacteria, synthesize IPP and DMAPP using the MEP pathway. In plants, both pathways are present. The MEP pathway functions in the plastids whereas the MVA pathways functions in the cytosol.
  • Isoprenoids are classified into groups according to the number of carbons in their skeletal structure: hemiterpenes (C5), monoterpenes (CIO), sesquiterpenes (CI 5), diterpenes (C20), triterpenes (C30) and tetraterpenes (C40); see Table 1.
  • the biosynthesis of isoprenoids can thus be divided into three major steps: 1) formation of the metabolic intermediates IPP and DMAPP 2) the linear condensation of the isoprene units to form polyprenyl diphosphates precursors of different lengths and 3) cyclization, modification and other reactions by which the polyprenyl diphosphates are converted to a variety of terpene end-products. Furthermore, modification (often oxidative) such as addition of functional groups such as carbonyl, ketone, hydroxyl, aldehyde and peroxide, leads to further diversity and such new compounds are often referred to as terpenoids. Terpenes and terpenoids are together referred to as isoprenoids.
  • Monoterpenes have been known for several centuries as components of the fragrant oils obtained from leaves, flowers and fruits. Monoterpenes, with sesquiterpenes, are the main constituents of essential oils. While a few, such as camphor, occur in a near pure form, most occur as complex mixtures, often of isomers that are difficult to separate. These terpenes in essential oils have numerous actions, such as allelochemical functions between plants and between plants and predators. A role in wound healing has also been observed.
  • the inventors of the present invention have arrived at a scalable process for the production of a monoterpene in cyanobacteria.
  • the invention combines metabolic properties of photoautotrophic and chemotrophic microorganisms and is based on the employment of recombinant oxyphototrophs with high rates of conversion of Calvin cycle intermediates to a desired end product.
  • One advantage resides in the fact that its core chemical reactions use carbon dioxide as the sole carbon-containing precursor and light (preferably sunlight), as the sole energy source, to drive carbon dioxide reduction.
  • the cyanobacterial cell factory is more suitable for production of a monoterpene than other microorganism used in fermentation processes such as E.coli and yeasts, since the abundantly available co-factor in the cyanobacterial cell is NADPH, rather than NADH in most chemotrophic organisms used for fermentation.
  • NADPH is produced directly from photosynthesis and is also used in the fixing of CO 2 via the Calvin-Benson-Bensham cycle.
  • NADPH is abundant in phototrophic microorganisms like cyanobacteria. NADPH is mostly generated in - heterotrophic microorganisms via the pentose-phosphate cycle and its pool size is then relatively small compared to NADH.
  • NADPH As most industrially relevant chemicals are produced by NADPH consuming pathways, the NADPH pools in photosynthetic organisms provide a strong driving force for production of chemicals.
  • Production in a cyanobacterial cell according to the invention can be controlled by a nutrient- or light-sensitive promoter.
  • a nutrient- sensitive promoter Using a nutrient- sensitive promoter, production can be controlled by a medium component and can start at the most appropriate time, such as at the highest possible cell density.
  • a light-mediated promoter production can be controlled by light intensity.
  • microorganisms are used as highly specialized catalysts for the conversion of carbon dioxide as a substrate to a valuable end product. These catalysts can be subjected to further optimization strategies through physical- and chemical systems-biology approaches.
  • the biochemical background of cyanobacterial cells for the production of valuable compounds is more extensively described in WO 2009/078712, especially in example 1.
  • the various aspects of the present invention are more extensively described here below.
  • the present invention relates to a cyanobacterial cell capable of expressing, preferably expressing, at least one functional enzyme selected from the group of enzymes consisting of a geranyl diphosphate synthase (GPPS) and a monoterpene synthase (MTS).
  • GPPS geranyl diphosphate synthase
  • MTS monoterpene synthase
  • Said cyanobacterial cell is herein further referred to as a cyanobacterial cell according to the present invention.
  • the cyanobacterial cell according to the present invention is preferably capable of producing a monoterpene selected from the group consisting of: limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, citral, ⁇ -terpinene, ⁇ - ⁇ - ocimene, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, the monoterpene is limonene or linalool; most preferably, the monoterpene is limonene.
  • GPPS geranyldiphosphate synthase
  • IPP isopentenyl diphosphate
  • DMAPP dimethylallyl diphosphate
  • microorganisms do not carry a specific GPPS.
  • yeast both GPP and farnesyl diphosphate (FPP) synthase activities are shared by one single enzyme Farnesyl diphosphate synthase (FPPS) and these can consequently not be separated.
  • FPP farnesyl diphosphate
  • FPPS Farnesyl diphosphate synthase
  • dedicated GPPS enzymes have been reported in literature from plants.
  • the term "functional enzyme” is herein preferably defined in the context of a monoterpene synthase as an enzyme able to convert the acyclic GPP produces by the GPPS enzyme into a variety of cyclic and acyclic forms.
  • a preferred cyanobacterial cell according to the invention is capable of expressing, preferably expressing, at least one functional enzyme selected from the group consisting of enzymes having ability to condense IPP and DMAPP to GPP.
  • the enzyme may be native or may be heterologous to the cyanobacterial cell according to the present invention.
  • the at least one functional enzyme is preferably selected from the group consisting of GPPS from Abies grandis, Picea abies, Arabidopsis thaliana and Saccharomyces cerevisiae. More preferably, the GPPS is from Abies grandis.
  • the enzyme may be a mutant of a prenyphosphate synthase enzyme, with specificity for forming GPP.
  • the functional enzyme may be an N- terminal truncated version of the original protein, while substantially maintaining its monoterpene synthase activity.
  • At least one functional enzyme is preferably selected from the group consisting of monoterpene synthases, which are enzymes having the ability of converting GPP to various cyclic or acyclic monoterpenes.
  • the at least one functional enzyme may be native or may be heterologous to the cyanobacterial cell and is preferably selected from the group consisting of monoterpene synthases from Mentha spicata, Mentha Canadensis, Abies grandis, Citrus sinensis, Mentha citrata, Citrus unshiu, Thymus caespititius, Origanum vulgare and Lotus japonicas.
  • the monoterpene synthase is from Mentha spicata or from Mentha citrata.
  • the functional enzyme may be an N-terminal truncated version of the original protein, while substantially maintaining its monoterpene synthase activity.
  • at least two functional enzymes are heterologous to the cyanobacterial cell.
  • a cynabacterial cell according to the present invention is capable of expressing, preferably expressing, at least one functional enzyme selected from the group of enzymes consisting of a Geranyl diphosphate synthase (GPPS) and a monoterpenes synthase (MTS), wherein the at least one functional enzyme is selected from the group consisting of GPPS from Abies grandis, Picea abies, Arabidopsis thaliana, and Saccharomyces cerevisiae; and/or wherein the at least one functional enzyme is selected from the group consisting of monoterpene synthases from Mentha spicata, Mentha Canadensis, Abies grandis, and Citrus sinensis, Mentha citrata, Citrus unshiu, Thymus caespititius, Origanum vulgare and Lotus japonicas.
  • GPPS Geranyl diphosphate synthase
  • MTS monoterpenes synthase
  • the GPPS is from Abies grandis and the monoterpene synthase is from Mentha spicata or the GPPS is from Abies grandis and the monoterpene synthase is from Mentha citrata.
  • preferred cyanobacterial cell according to the present invention is capable of producing, preferably producing, a monoterpene, preferably a monoterpene selected from the group consisting of: limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, citral, ⁇ -terpinene, ⁇ - ⁇ -ocimene, terpineol, myrcene, citronellol, carvone and geraniol.
  • the monoterpene is limonene or linalool; most preferably, the monoterpene is limonene.
  • a cyanobacterial cell according to the present invention is capable of producing, preferably producing, at least two terpenes, more preferably at least two monoterpenes.
  • the at least one functional enzyme preferably comprises or consists of a polypeptide that has an amino acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26 and SEQ ID NO: 28.
  • the at least one functional enzyme comprises or consists of a polypeptide that has an amino acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 6 or from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 18.
  • the at least one functional enzyme are at least two functional enzymes comprising or consisting of two polypeptides that have an amino acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with SEQ ID NO: 2 and SEQ ID NO: 6, or with SEQ ID NO: 2 and SEQ ID NO: 18, respectively.
  • the at least one functional enzyme is preferably encoded by a polynucleotide that has a nucleic acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 91%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11 , SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25 and SEQ ID NO: 27.
  • the at least one functional enzyme is encoded by a polynucleotide that has a nucleic acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 5 or from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 17.
  • the at least one functional enzyme are at least two functional enzymes that are encoded by a polynucleotide that has a nucleic acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with SEQ ID NO: 1 and SEQ ID NO: 5, or with SEQ ID NO: 1 and SEQ ID NO: 17, respectively.
  • a cyanobacterium In the context of all embodiments of the present invention, the terms “a cyanobacterium”, “a cyanobacterium cell” and “a cyanobacterial cell” are used interchangeably and refer to a blue- green algae, an oxygenic photosynthetic unicellular microorganism.
  • cyanobacteria include the genera Aphanocapsa, Anabaena, Nostoc, Oscillatoria, Synechococcus, Synechocystis, Gloeocapsa, Agmenellum, Scytonema, Mastigocladus, Arthrosprira, and aplo siphon.
  • a preferred order of cyanobacteria is Chroococcales.
  • a more preferred cyanobacterium genus is Synechocystis.
  • Synechocystis is well-studied, genetically well characterized and it does not require special media components for growth. Most importantly, it can grow mixotrophically, which means that it can grow on glucose in the absence of light. This makes Synechocystis robust for industrial applications.
  • a more preferred strain of this genus is a Synechocystis PCC 6803 species. Even more preferably, the Synechocystis is a Pasteur Culture Collection (PCC) 6803 Synechocystis, which is a publicly available strain via ATCC for example. PCC 6803 has been stored at ATCC under ATCC27184.
  • the phototrophic Synechocystis PCC 6803 is a fast growing cyanobacterium with no specific nutritional demands. Its physiological traits are well-documented: it is able to survive and grow in a wide range of conditions. For example, Synechocystis sp. PCC 6803 can grow in the absence of photosynthesis if a suitable fixed-carbon source such as glucose is provided. Perhaps most significantly, Synechocystis sp. PCC 6803 was the first photosynthetic organism for which the entire genome sequence was determined (available via the internet world wide web at kazusa.or.jp/cyano/cyano).
  • the cyanobacterium is preferably not from the genus Anabaena.
  • Capable of producing monoterpene preferably means herein that detectable amounts of monoterpene can be detected in a culture of a cyanobacterial cell according to the present invention cultured, under conditions conducive to the production of monoterpene, preferably in the presence of light and dissolved carbon dioxide and/or bicarbonate ions, during a preferred interval using a suitable assay for detecting monoterpenes. Detection may be in the culture broth (i.e. the medium including the cyanobacterial cell), in the medium or supernatant of the broth, in the cyanobacterial cell itself, and/or in the headspace of the culturing device.
  • a preferred concentration of said dissolved carbon dioxide and/or bicarbonate ions is, the natural occurring concentration at neutral to alkaline conditions (pH 7 to 9) being approximately 1 mM. This is equivalent to 0.035% of carbon dioxide in ambient air. A more preferred concentration of carbon dioxide and/or bicarbonate ions is higher than this natural occurring concentration.
  • the concentration of bicarbonate ions is at least 0.5mM, 0.6mM, 0.7mM, 0.8mM, 0.9mM, lmM, 2mM, 5mM, lOmM, 15mM, 20mM, 25mM, 30mM, 35mM, 40mM, 45mM, 50mM, 60mM, 70mM, 80mM, 90mM or lOOmM.
  • a preferred method to increase the carbon dioxide and/or bicarbonate ion concentrations in solution is by enrichment with carbon dioxide, preferably waste carbon dioxide from industrial plants, sparged into the culture broth.
  • the concentration of carbon dioxide is preferably increased to at least 0.04%, 0.05%, 0.1%, 0.15%, 0.2%, 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, or 5%.
  • the monoterpene is thus detected in a cyanobacterial cell according to the present invention and/or in its culture broth or headspace, wherein said cyanobacterial cell is cultured under conditions conducive to the production of a monoterpene, preferably the conditions include culturing in the presence of sunlight and carbon dioxide during at least 1 day using a given assay for the intermediary compound.
  • the monoterpene produced within the cyanobacterial cell according to the invention may spontaneously diffuse into the culture broth or the headspace or both.
  • Assays for the detection of a monoterpene are, but are not limited to, High Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Gas Chromatography-Mass Spectrometry (GC-MS), or Liquid Chromatography-Mass Spectrometry (LC-MS).
  • HPLC High Performance Liquid Chromatography
  • GC Gas Chromatography
  • GC-MS Gas Chromatography-Mass Spectrometry
  • LC-MS Liquid Chromatography-Mass Spectrometry
  • a preferred assay for the detection of a monoterpene is Gas Chromatography-Mass Spectrometry (GC-MS).
  • a detectable amount fof a monoterpene is preferably at least 1 ng/ml culture broth, 1 ng/gram dry weight of the culture broth or 1 ng/ml of culture supernatant which are preferably obtained under the culture conditions depicted here above and preferably using the above assay.
  • the amount is depicted as weight of product (ng, ⁇ g or mg)/gram dry weight of culture broth.
  • the amount is at least 2 ng, 3 ng, 4 ng, 5 ng, 6 ng, 7 ng, 8 ng, 9 ng, 10 ng, 15 ng, 20 ng, 25 ng, 30 ng, 35 ng, 40 ng, 45 ng, 50 ng, lOOng, 200ng, 300ng, 400ng, 500ng, 1 ⁇ g, 2 ⁇ g, 3 ⁇ g, 5 ⁇ g, 10 ⁇ g, 50 ⁇ g, 100 ⁇ g, 200 ⁇ g, 300 ⁇ g, 400 ⁇ g, 500 ⁇ g. lmg, 2 mg, 3 mg, 4 mg, 5 mg, 10 mg, or at least 100 mg/gram dry weight.
  • a cyanobacterial cell according to the present invention comprises at least one nucleic acid molecule comprising or consisting of a polynucleotide encoding at least one of the at least one functional enzyme as defined here above.
  • a preferred cyanobacterial cell according to the invention comprises at least one nucleic acid molecule comprising or consisting of a polynucleotide encoding at least one of the at least one functional enzyme as defined here above.
  • each encoding polynucleotide may be present on a separate nucleic acid molecule.
  • the encoding polynucleotides may be present on a single nucleic acid molecule.
  • a preferred cyanobacterial cell according to the invention is a cyanobacterial cell wherein the at least one functional enzyme is encoded by a nucleic acid molecule comprising or consisting of a polynucleotide wherein said nucleic acid molecule is preferably present in the cyanobacterial cell as an episomal entity, preferably said episomal entity is a plasmid, more preferably a self-replicating plasmid.
  • the episomal entity and plasmid can be any episomal entity and plasmid known to the person skilled in the art or can be based on any episomal entity and plasmid known to the person skilled in the art and modified to comprise any nucleic acid and/or polynucleotide described herein.
  • Another preferred cyanobacterial cell according to the invention is a cyanobacterial cell wherein the at least one functional enzyme is encoded by a nucleic acid molecule comprising or consisting of a polynucleotide wherein said nucleic acid molecule is preferably integrated in the cyanobacterial genome, preferably via homologous recombination.
  • a cyanobacterial cell according to the present invention may comprise a single but preferably comprises multiple copies of each nucleic acid molecule.
  • a preferred cyanobacterial cell according to the present invention is a cyanobacterial cell, wherein a polynucleotide encoding the at least one functional enzyme is under control of a regulatory system which responds to a change in the concentration of a nutrient when culturing said cyanobacterial cell.
  • a promoter that may be used for the expression of a polynucleotide encoding the at least one functional enzyme may be foreign to the polynucleotide, i.e. a promoter that is heterologous to the polynucleotide encoding the at least one functional enzyme to which it is operably linked.
  • a promoter preferably is heterologous to the polynucleotide to which it is operably linked, it is also possible that a promoter is native to the cyanobacterial cell according to the present invention.
  • a heterologous (to the nucleotide sequence) promoter is capable of producing a higher steady state level of a transcript comprising a coding sequence (or is capable of producing more transcript molecules, i.e.
  • a suitable promoter in this context includes both constitutive and an inducible natural promoters as well as engineered promoters.
  • a promoter used in a cyanobacterial cell according to the present invention may be modified, if desired, to affect its control characteristics.
  • a preferred promoter for constitutive expression is a Ptrc, as is further outlined below in the next paragraph.
  • the Ptrc promoter is an artificial promoter, which is constructed as a chimera of the E. coli trp operon and lacUV5 promoters (Brosius et al, J Biol Chem 1985).
  • the promoter is thus regulated by the Lac repressor, Lacl.
  • the Lacl regulated repression and induction does not function efficiently, but the Ptrc promoter does show high constitutive expression levels in the absence of Lacl (Huang H-H, Camsund D, Lindblad P, Heidorn T: Design and characterization of molecular tools for a Synthetic Biology approach towards developing cyanobacterial biotechnology. Nucleic Acids Res 2010, 38:2577-2593).
  • the cyanobacterial cell according to the present invention can conveniently be used for the production of a monoterpene.
  • the present invention relates to a process for producing a monoterpene comprising culturing a cyanobacterial cell according to the present invention, preferably a cyanobacterial cell as defined in the first aspect of the present invention, under conditions conducive to the production of a monoterpene and, optionally, isolating and/or purifying the monoterpene from the culture broth and/or its headspace.
  • Said process is herein further referred to as a process according to the present invention.
  • a process according to the present invention for producing a monoterpene comprises culturing a cyanobacterial cell according to the present invention, preferably a cyanobacterial cell as defined in the first aspect of the present invention, wherein the culture conditions comprise feeding carbon dioxide to the culture and/or subjecting the culture to light.
  • a culture also named culture or culture broth
  • the cell number in the culture doubles every 20 hours.
  • a preferred process takes place in a tank with a depth of 30-50 cm exposed to sun light.
  • the light used is natural.
  • a preferred natural light is daylight, i.e. sunlight.
  • Daylight or sunlight
  • the light used is artificial.
  • Such artificial light may have an intensity ranged between approximately 70 and approximately 800 ⁇ / ⁇ 2/s.
  • the cells are continuously under the light conditions as specified herein.
  • the cells may also be exposed to high light intensities (such as e.g. daylight/sunlight) as defined elsewhere herein for a certain amount of time, after which the cells are exposed to a lower light intensity as defined elsewhere herein for a certain amount of time, and optionally this cycle is repeated.
  • the cycle is the day/night cycle.
  • the monoterpene is separated from the culture broth. This may be realized continuously with the production process or subsequently to it. Separation may be based on any separation method known to the person skilled in the art.
  • the produced monoterpene is selected from the group consisting of: limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, citral, ⁇ -terpinene, ⁇ - ⁇ -ocimene, terpineol, myrcene, citronellol, carvone and geraniol.
  • the monoterpene is limonene, linalool, ⁇ -terpinene or ⁇ - ⁇ - ocimene; even more preferably limonene or linalool; most preferably the monoterpene is limonene.
  • at least two terpenes are produced, more preferably at least two monoterpenes as described herein are produced.
  • a monoterpene produced by a cyanobacterial cell according to the invention and by a process according to the invention have specific properties. Accordingly, there is provided for a monoterpene obtainable by a cyanobacterial cell according to the invention and by a process according to the invention.
  • such monoterpene is a monoterpene selected from the group consisting of limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, ⁇ -terpinene, ⁇ - ⁇ -oc imene, citral, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, such monoterpene is a monoterpene selected from the group consisting of limonene, linalool, ⁇ -terpinene and ⁇ - ⁇ -ocimene.
  • a monoterpene according to the invention can conveniently be used in a product. Accordingly, there is provided for a pharmaceutical composition, a fuel composition, a flavor composition, a flagrance composition or a cosmetic composition comprising a monoterpene obtainable by a cyanobacterial cell according to the invention and by a process according to the invention.
  • such composition comprises a monoterpene selected from the group consisting of limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, ⁇ -terpinene, ⁇ - ⁇ -ocimene, citral, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, such composition comprises a monoterpene selected from the group consisting of limonene, linalool, ⁇ -terpinene and ⁇ - ⁇ -ocimene.
  • sequence identity in the context of amino acid- or nucleic acid-sequence is herein defined as a relationship between two or more amino acid (peptide, polypeptide, or protein) sequences or two or more nucleic acid (nucleotide, polynucleotide) sequences, as determined by comparing the sequences.
  • identity also means the degree of sequence relatedness between amino acid or nucleotide sequences, as the case may be, as determined by the match between strings of such sequences.
  • sequence identity with a particular sequence preferably means sequence identity over the entire length of said particular polypeptide or polynucleotide sequence.
  • the sequence information as provided herein should not be so narrowly construed as to require inclusion of erroneously identified bases. The skilled person is capable of identifying such erroneously identified bases and knows how to correct for such errors.
  • Similarity between two amino acid sequences is determined by comparing the amino acid sequence and its conserved amino acid substitutes of one peptide or polypeptide to the sequence of a second peptide or polypeptide. In a preferred embodiment, identity or similarity is calculated over the whole SEQ ID NO as identified herein. "Identity” and “similarity” can be readily calculated by known methods, including but not limited to those described in Computational Molecular Biology, Lesk, A. M., ed., Oxford University Press, New York, 1988; Biocomputing: Informatics and Genome Projects, Smith, D. W., ed., Academic Press, New York, 1993; Computer Analysis of Sequence Data, Part I, Griffin, A. M., and Griffin, H.
  • Preferred methods to determine identity are designed to give the largest match between the sequences tested. Methods to determine identity and similarity are codified in publicly available computer programs. Preferred computer program methods to determine identity and similarity between two sequences include e.g. the GCG program package (Devereux, J., et al., Nucleic Acids Research 12 (1): 387 (1984)), BestFit, BLASTP, BLASTN, and FASTA (Altschul, S. F. et al, J. Mol. Biol. 215:403-410 (1990).
  • the BLAST X program is publicly available from NCBI and other sources (BLAST Manual, Altschul, S., et al, NCBI NLM NIH Bethesda, MD 20894; Altschul, S., et al., J. Mol. Biol. 215:403-410 (1990).
  • the well- known Smith Waterman algorithm may also be used to determine identity.
  • Preferred parameters for polypeptide sequence comparison include the following: Algorithm: Needleman and Wunsch, J. Mol. Biol. 48:443-453 (1970); Comparison matrix: BLOSSUM62 from Hentikoff and Hentikoff, Proc. Natl. Acad. Sci. USA. 89:10915-10919 (1992); Gap Penalty: 12; and Gap Length Penalty: 4.
  • a program useful with these parameters is publicly available as the "Ogap" program from Genetics Computer Group, located in Madison, WI. The aforementioned parameters are the default parameters for amino acid comparisons (along with no penalty for end gaps).
  • amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine; a group of amino acids having amide- containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulphur- containing side chains is cysteine and methionine.
  • Preferred conservative amino acids substitution groups are: valine-leucine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, and asparagine-glutamine.
  • Substitutional variants of the amino acid sequence disclosed herein are those in which at least one residue in the disclosed sequences has been removed and a different residue inserted in its place.
  • the amino acid change is conservative.
  • Preferred conservative substitutions for each of the naturally occurring amino acids are as follows: Ala to ser; Arg to lys; Asn to gin or his; Asp to glu; Cys to ser or ala; Gin to asn; Glu to asp; Gly to pro; His to asn or gin; He to leu or val; Leu to ile or val; Lys to arg; gin or glu; Met to leu or ile; Phe to met, leu or tyr; Ser to thr; Thr to ser; Trp to tyr; Tyr to trp or phe; and, Val to ile or leu.
  • a polynucleotide is represented by a nucleotide sequence.
  • a polypeptide is represented by an amino acid sequence.
  • a nnucleic acid construct is defined as a polynucleotide which is isolated from a naturally occurring gene or which has been modified to contain segments of polynucleotides which are combined or juxtaposed in a manner which would not otherwise exist in nature.
  • a polynucleotide present in a nucleic acid construct is operably linked to one or more control sequences, which direct the production or expression of said peptide or polypeptide in a cell or in a subject.
  • Polynucleotides described herein may be native or may be codon optimized. Codon optimization adapts the codon usage for an encoded polypeptide towards the codon bias of the organism where the polypeptide is to be produced in. Codon optimization generally helps to increase the production level of the encoded polypeptide in the host cell, such as in the preferred host herein: Cyanobacterium Synechocystis . Many algorithms are available to the person skilled in the art for codon optimization. A preferred method is the "guided random method based on a Monte Carlo algorithm available via the internet world wide web genomes.urv.es/OPTIMIZER/ (P. Puigbo, E. Guzman, A. Romeu, and S. Garcia- Vallve. Nucleic Acids Res. 2007 July; 35(Web Server issue): W126-W131).
  • a nucleotide sequence encoding an enzyme expressed or to be expressed in a cyanobacterial cell according to the invention or a promoter used in a cell according to the invention may be defined by its capability to hybridize with a nucleotide sequence such as SEQ ID NO: 1, 3, or 5 respectively, under moderate, or preferably under stringent hybridization conditions.
  • Stringent hybridization conditions are herein defined as conditions that allow a nucleic acid sequence of at least about 25, preferably about 50 nucleotides, 75 or 100 and most preferably of about 200 or more nucleotides, to hybridize at a temperature of about 65° C. in a solution comprising about 1 M salt, preferably 6 X SSC or any other solution having a comparable ionic strength, and washing at 65° C.
  • the hybridization is performed overnight, i.e. at least for 10 hours and preferably washing is performed for at least one hour with at least two changes of the washing solution.
  • These conditions will usually allow the specific hybridization of sequences having about 90% or more sequence identity.
  • Moderate conditions are herein defined as conditions that allow a nucleic acid sequences of at least 50 nucleotides, preferably of about 200 or more nucleotides, to hybridize at a temperature of about 45° C.
  • the hybridization is performed overnight, i.e. at least for 10 hours, and preferably washing is performed for at least one hour with at least two changes of the washing solution.
  • These conditions will usually allow the specific hybridization of sequences having up to 50% sequence identity. The person skilled in the art will be able to modify these hybridization conditions in order to specifically identify sequences varying in identity between 50% and 90%.
  • heterologous sequence or “heterologous nucleic acid” is one that is not naturally found operably linked as neighboring sequence of said first nucleotide sequence.
  • heterologous may mean “recombinant”.
  • Recombinant refers to a genetic entity distinct from that generally found in nature. As applied to a nucleotide sequence or nucleic acid molecule, this means that said nucleotide sequence or nucleic acid molecule is the product of various combinations of cloning, restriction and/or ligation steps, and other procedures that result in the production of a construct that is distinct from a sequence or molecule found in nature.
  • Operaably linked is defined herein as a configuration in which a control sequence is appropriately placed at a position relative to the nucleotide sequence coding for the polypeptide of the invention such that the control sequence directs the production/expression of the peptide or polypeptide of the invention in a cell and/or in a subject.
  • “Operably linked” may also be used for defining a configuration in which a sequence is appropriately placed at a position relative to another sequence coding for a functional domain such that a chimeric polypeptide is encoded in a cell and/or in a subject.
  • Expression will be understood to include any step involved in the production of the peptide or polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification and secretion.
  • promoter refers to a nucleic acid fragment that functions to control the transcription of one or more nucleic acid molecules, located upstream with respect to the direction of transcription of the transcription initiation site of the nucleic acid molecule, and is structurally identified by the presence of a binding site for DNA-dependent R A polymerase, transcription initiation sites and any other DNA sequences, including, but not limited to transcription factor binding sites, repressor and activator protein binding sites, and any other sequences of nucleotides known to one of skill in the art to act directly or indirectly to regulate the amount of transcription from the promoter.
  • a “constitutive” promoter is a promoter that is active under most environmental and developmental conditions.
  • An “inducible” promoter is a promoter that is active under environmental or developmental regulation.
  • the cell can be transformed with a nucleic acid or nucleic acid construct described herein by any method known to the person skilled in the art.
  • Such methods are e.g. known from standard handbooks, such as Sambrook and Russel (2001) "Molecular Cloning: A Laboratory Manual (3 rd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, or F. Ausubel et al, eds., "Current protocols in molecular biology", Green Publishing and Wiley Interscience, New York (1987).
  • Methods for transformation and genetic modification of cyanobacterial cells are known from e.g. U.S. Pat. No.
  • a selectable marker may be present in the nucleic acid construct comprising a polynucleotide encoding the enzyme.
  • the term "marker” refers herein to a gene encoding a trait or a phenotype which permits the selection of, or the screening for, a cyanobacterial cell containing the marker.
  • a marker gene may be an antibiotic resistance gene whereby the appropriate antibiotic can be used to select for transformed cells from among cells that are not transformed.
  • a non-antibiotic resistance marker is used, such as an auxotrophic marker (URA3, TRP1, LEU2).
  • a preferred cyanobacterial cell according to the invention e.g. transformed with a nucleic acid construct, is marker gene free. Methods for constructing recombinant marker gene free microbial host cells are described in (Cheah et al., 2013) and are based on the use of bidirectional markers.
  • a screenable marker such as Green Fluorescent Protein, lacZ, luciferase, chloramphenicol acetyltransferase, beta-glucuronidase may be incorporated into a nucleic acid construct according to the invention allowing to screen for transformed cells.
  • nucleic acid constructs include, but are not limited to, one or more leader sequences, enhancers, integration factors, and/or reporter genes, intron sequences, centromers, telomers and/or matrix attachment (MAR) sequences.
  • a nucleic acid construct according to the invention can be provided in a manner known per se, which generally involves techniques such as restricting and linking nucleic acids/nucleic acid sequences, for which reference is made to the standard handbooks, such as Sambrook and ussel (2001) "Molecular Cloning: A Laboratory Manual (3 rd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press.
  • the word "about” or “approximately” when used in association with a numerical value preferably means that the value may be the given value (of 10) more or less 0.1% of the value.
  • sequence information as provided herein should not be so narrowly construed as to require inclusion of erroneously identified bases.
  • the skilled person is capable of identifying such erroneously identified bases and knows how to correct for such errors.
  • sequence errors the sequence of the enzymes obtainable by expression of the genes as represented by SEQ ID NO's 1, 3, 5, 7, 9, 1 1, 13, 15, 17, 19, 21 , 23, 25 and 27 containing the enzyme encoding polynucleotide sequences should prevail.
  • VDQVEKX PRNVDIALEYLG SKGIQRARELAMEHANL
  • the inventors have introduced a specific two-enzyme pathway into a cyanobacterial cell to produce limonene.
  • Limonene is a simple cyclic CIO terpene with no rare groups. Limonene is chiral and exists in two enantiomeric forms R-limonene and S-limonene. In nature R-limonene is the most abundant and is commercially harvested from citrus rinds. The other enantiomer S-limonene enantiomer is also found in nature and is the precursor for menthol.
  • Limonene like other monoterpenes is made in two steps from the isoprenoid precursors.
  • IPP and DMAPP are condensed by Geranyl diphosphate synthase (GPPS) to form geranyl diphosphate (GPP).
  • GPP Geranyl diphosphate synthase
  • the enzyme Limonene Synthase (LS) catalyzes the cyclization of GPP to limonene.
  • LS Limonene Synthase
  • the genes encoding the LS from Mentha spicata and the GPPS from Abies grandis were co don-optimized for expression in Synechocystis and obtained through chemical synthesis. While the erg20 gene was amplified from Saccharomyces cerevisiae and the mutation Kl 97A was introduced by overlap-extention PCR. These genes were each cloned with a trc promoter into an integration vector, containing sequences to facilitate (double) homologous recombination with the neutral site slrO 168 in the cyanobacterial genome, and a kanamycin marker, which confers resistance to kanamycin. The genes were introduced either as operons, with both genes sharing the same trc promoter or as independent transcription cassettes, with a trc promoter for each gene. This led to making of 4 plasmids,
  • 2mL or 4mL of a select culture was transferred to a 20 mL glass vial and sealed.
  • 10 to 20 mM of bicarbonate was also added to each vial and the vial incubated in low light intensity ( ⁇ 40 ⁇ ), 30° C, and shaking at 120 rpm light overnight.
  • the vial was loaded onto an automated GCMS (Agilent Technologies 7200 Accurate-Mass Q-TOF GCMS). In the first step, the vial was heated for 10 min at 55 deg C, to release all volatiles into the headspace.
  • the inventors have introduced a specific two-enzyme pathway into a cyanobacterial cell to produce linalool.
  • Linalool is a non cyclic CIO terpene with a hydroxyl-group. It is chiral and exists in two enantiomeric forms (R)-(-)-linalool also known as licareol and (S)-(+)-linalool also known as coriandrol. (S)-(+)-Linalool is perceived as sweet, floral, petit grain- like and the (R)-form as more woody and lavender-like. In nature R-linalool found in lavender oil while the other enantiomer S-linalool is found in coriander oil.
  • Linalool like limonene and other monoterpenes is made in two steps from the isoprenoid precursors.
  • IPP and DMAPP are condensed by Geranyl diphosphate synthase (GPPS) to form geranyl diphosphate (GPP).
  • GPPS Geranyl diphosphate synthase
  • LS Linalool Synthase
  • LinS linalool synthase
  • ⁇ -terpinene can be made using the the ⁇ -terpinene synthase from Citrus unshiu (SEQ ID NO: 19, 20); Thymus caespititius (SEQ ID NO: 21, 22), Origanum vulgare (SEQ ID NO: 23, 24).
  • ⁇ - ⁇ -ocimene can be made using the the ⁇ - ⁇ -ocimene synthase from Lotus japonicus (SEQ ID NO: 25, 26) and Arabidopsis thaliana (SEQ ID NO: 27, 28).
  • the genes encoding the Linalool synthase (LinS) from Mentha citrata and the GPPS from Abies grandis as described in Example 4 were co don-optimized for expression in Synechocystis and obtained through chemical synthesis. These genes were each cloned with a trc promoter into an integration vector ( Figure 3), containing sequences to facilitate (double) homologous recombination with the neutral site slr0168 in the cyanobacterial genome, and a kanamycin marker, which confers resistance to kanamycin. The genes were introduced as independent transcription cassettes, with a trc promoter for each gene. The genes were also cloned into a RSFlOlO-based conjugative plasmid pVZ ( Figure 4) as independent transcription cassettes. This led to the provision of two plasmids,
  • the photobioreactors were bubbled with air/carbon-dioxide mixture and linalool formed was trapped on Supelpak SV reisn.
  • the bound terpene was eluted with hexane and the eluate was analyzed by GC FID.
  • Standard solution of linalool in hexane were used to obtain a calibration curve for quantitative determination.
  • a wild- type culture was used a negative control. Linalool elutes at a retention time of around 7.2 minutes. Both strains obtained in example 2: integrated and plasmid were tested.
  • Figure 6 shows the FID units vs acquisition time plots obtained from GC analysis. From the figure, it is evident that both strains tested produce linalool while the wild-type strain did not produce any linalool.
  • Figure 7 shows that linalool can be produced in continuously growing cultures and maximum production rates of about 120 ⁇ g/gDW/L/day were achieved.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The present invention relates to a process for producing a monoterpene and to a cyanobacterial cell for the production of a monoterpene.

Description

Biosynthesis of monoterpenes in cyanobacteria
Field of the invention
The present invention relates to a process for producing a monoterpene and to a cyanobacterial cell for the production of a monoterpene.
Background of invention
Isoprenoids (commonly known as terpenes) are comprised of diverse group of molecules found in all organisms, where they carry out important biological functions. For example, as quinones in electron transport, as components of membranes (prenyl-lipids in archaebacteria, sterols in eukaryotes), in subcellular targeting (prenylation of proteins), in hormone signaling in mammals (steroids), as photosynthetic pigments (carotenoids) and as semiochemical secondary metabolites in plants (monoterpenes, sesquiterpenes, diterpenes). They are the most abundant and structurally diverse natural products with more than 55,000 identified in bacteria, archaea and eukaryotes. Some are also commercially important as pharmaceutical ingredients, flavors, fragrances, cosmetic ingredients and also have been explored as precursors to alternative fuel.
However, many such compounds are present in nature in very small quantities or low yielding from their natural sources to be used widely for above applications. Moreover, most of the natural sources are not amenable to large-scale cultivation necessary to produce large quantities. Furthermore, the extractions from natural source involve the use of toxic organic chemicals necessitating the need for complicated handling and disposal procedures. Microbial fermentations involving genetically modified yeast or bacteria have recently gained lots of attention as a potential source for terpenes. This has been described in patent applications: 1) US 20110229958: Host Cells for Production of Isoprenoid Compounds; 2) US 20100112672: Production of isoprenoids and isoprenoid precursors and 3) EP 1392824: Improved isoprenoid production. However, standard fermentation processes require a carbon source, for which plants and algal species are employed to reduce carbon dioxide via photosynthesis (using the energy of the sun) to the level of sugars and cell material. After harvesting, these end products are converted to ethanol by yeast fermentation (in the case of crops) or converted chemically to biofuels (in the case of algae). The overall energy conservation of these methods is highly inefficient and therefore demands large surface areas. In addition, the crop processes are rather labor-intensive, are demanding with respect to water consumption and affect food stock prices with adverse consequences for food supplies. A more remotely similar process is based on the conversion of solar energy into hydrogen. Also this process suffers from a severely decreased efficiency.
U.S. Pat. No. 6,699,696 describes a process of producing ethanol by feeding carbon dioxide to a cyanobacterial cell, especially a Synechococcus comprising a nucleic acid molecule encoding an enzyme enabling the cell to convert pyruvate into ethanol, subjecting said cyanobacterial cell to sun energy and collecting ethanol. This system has several drawbacks among others the expression system used is temperature sensitive which demands to adapt the production system for such regulation.
WO 2009/078712 describes a process of producing ethanol, propanol, butanol, acetone, 1,3- propanediol, ethylene or D-lactate and where appropriate intermediary compounds in the pathway leading to any of these organic compounds. The process is carried out by feeding carbon dioxide to a culture of cyanobacterial cells and subjecting the culture to light, wherein the cells are capable of expressing a nucleic acid molecule under the control of a regulatory system which responds to a change in the concentration of a nutrient in the culture which confers on the cell the ability to convert a glycolytic intermediate into the above-mentioned organic compounds and/or into intermediary compounds.
Similar approaches for the production of some terpenes in the cyanobacteria Anabaena and Synechococcus have recently been suggested in "Genetically engineered cyanobacteria WO 2012116345 A2" and in "Methods for Isoprene and Pinene Production in Cyanobacteria US 20140030785 Al".
All isoprenoids are derived from five-carbon isoprene units and are synthesized from two universal C5 building blocks: isopentenyl diphosphate (IPP) and its isomer dimethylallyl diphosphate (DMAPP), which in turn can be produced by two distinct well studied routes: the mevalonate (MVA) pathway (see Figure 1) or the l-deoxy-D-xylulose-5-phosphate (DXB) pathway (the DXB pathway is also referred to as the MEP pathway based on another intermediate "2-C-methyl-D-erythritol-4-phosphate"); see Figure 2. Both pathways are distributed throughout nature. The MVA pathway is present in all eukaryotes (mammals, fungi etc.) and all archaea. Some Gram positive bacteria like Staphylococcus, Streptococcus, Enterococcus, Lactococcus, Lactobacillus, and Leuconostoc, and some Gram negative bacteria like Myxobacteria, also use the MVA pathway, whereas most other bacteria, including cyanobacteria, synthesize IPP and DMAPP using the MEP pathway. In plants, both pathways are present. The MEP pathway functions in the plastids whereas the MVA pathways functions in the cytosol. Isoprenoids are classified into groups according to the number of carbons in their skeletal structure: hemiterpenes (C5), monoterpenes (CIO), sesquiterpenes (CI 5), diterpenes (C20), triterpenes (C30) and tetraterpenes (C40); see Table 1.
The biosynthesis of isoprenoids can thus be divided into three major steps: 1) formation of the metabolic intermediates IPP and DMAPP 2) the linear condensation of the isoprene units to form polyprenyl diphosphates precursors of different lengths and 3) cyclization, modification and other reactions by which the polyprenyl diphosphates are converted to a variety of terpene end-products. Furthermore, modification (often oxidative) such as addition of functional groups such as carbonyl, ketone, hydroxyl, aldehyde and peroxide, leads to further diversity and such new compounds are often referred to as terpenoids. Terpenes and terpenoids are together referred to as isoprenoids.
Table 1. Classification of Terpenes
Figure imgf000004_0001
Monoterpenes have been known for several centuries as components of the fragrant oils obtained from leaves, flowers and fruits. Monoterpenes, with sesquiterpenes, are the main constituents of essential oils. While a few, such as camphor, occur in a near pure form, most occur as complex mixtures, often of isomers that are difficult to separate. These terpenes in essential oils have numerous actions, such as allelochemical functions between plants and between plants and predators. A role in wound healing has also been observed. Although the production of some terpenes in cyanobacteria from CO2 has recently been reported, there is still a need for an improved process for the biosynthesis of monoterpenes, preferably without the need of expensive or complicated starting materials, and/or the use of toxic organic chemicals necessitating the need for complicated handling and disposal procedure.
Description of the invention
In brief, the inventors of the present invention have arrived at a scalable process for the production of a monoterpene in cyanobacteria. The invention combines metabolic properties of photoautotrophic and chemotrophic microorganisms and is based on the employment of recombinant oxyphototrophs with high rates of conversion of Calvin cycle intermediates to a desired end product. One advantage resides in the fact that its core chemical reactions use carbon dioxide as the sole carbon-containing precursor and light (preferably sunlight), as the sole energy source, to drive carbon dioxide reduction. Moreover, the cyanobacterial cell factory is more suitable for production of a monoterpene than other microorganism used in fermentation processes such as E.coli and yeasts, since the abundantly available co-factor in the cyanobacterial cell is NADPH, rather than NADH in most chemotrophic organisms used for fermentation. NADPH is produced directly from photosynthesis and is also used in the fixing of CO2 via the Calvin-Benson-Bensham cycle. NADPH is abundant in phototrophic microorganisms like cyanobacteria. NADPH is mostly generated in - heterotrophic microorganisms via the pentose-phosphate cycle and its pool size is then relatively small compared to NADH. As most industrially relevant chemicals are produced by NADPH consuming pathways, the NADPH pools in photosynthetic organisms provide a strong driving force for production of chemicals. Production in a cyanobacterial cell according to the invention can be controlled by a nutrient- or light-sensitive promoter. Using a nutrient- sensitive promoter, production can be controlled by a medium component and can start at the most appropriate time, such as at the highest possible cell density. By using a light-mediated promoter, production can be controlled by light intensity. Whereas in current production processes for biochemicals, organisms are substrate (e.g., crops in ethanol production) or product (e.g., microalgae as biodiesel), herein microorganisms are used as highly specialized catalysts for the conversion of carbon dioxide as a substrate to a valuable end product. These catalysts can be subjected to further optimization strategies through physical- and chemical systems-biology approaches. The biochemical background of cyanobacterial cells for the production of valuable compounds is more extensively described in WO 2009/078712, especially in example 1. The various aspects of the present invention are more extensively described here below.
In a first aspect, the present invention relates to a cyanobacterial cell capable of expressing, preferably expressing, at least one functional enzyme selected from the group of enzymes consisting of a geranyl diphosphate synthase (GPPS) and a monoterpene synthase (MTS). Said cyanobacterial cell is herein further referred to as a cyanobacterial cell according to the present invention. The cyanobacterial cell according to the present invention is preferably capable of producing a monoterpene selected from the group consisting of: limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, citral, γ-terpinene, Ε-β- ocimene, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, the monoterpene is limonene or linalool; most preferably, the monoterpene is limonene.
The term "functional enzyme" is herein preferably defined in the context of a geranyldiphosphate synthase (GPPS) as an enzyme that catalyzes the condensation of two C5 co-substrates, isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP), to produce geranyl diphosphate (GPP) the precursor of all monoterpenes. Despite the multiple functions of monoterpenes, which are found most commonly in plants and insects where they act as essential oils and pheromones, respectively, our understanding of their biosynthesis remains limited. GPPS genes have been characterized from only a handful of plant species and, so far, only one study has reported on the existence of a GPPS in an insect. Unlike plants, microorganisms do not carry a specific GPPS. In yeast, both GPP and farnesyl diphosphate (FPP) synthase activities are shared by one single enzyme Farnesyl diphosphate synthase (FPPS) and these can consequently not be separated. However, dedicated GPPS enzymes have been reported in literature from plants. The term "functional enzyme" is herein preferably defined in the context of a monoterpene synthase as an enzyme able to convert the acyclic GPP produces by the GPPS enzyme into a variety of cyclic and acyclic forms. It may also refer to a mutant of a prenyl phoshphate synthase enzyme, more preferably a Farnesyl phosphate synthase enzyme, where in one or more amino acids have been mutated, such that the enzyme makes GPP as the preferred product.
A preferred cyanobacterial cell according to the invention is capable of expressing, preferably expressing, at least one functional enzyme selected from the group consisting of enzymes having ability to condense IPP and DMAPP to GPP. The enzyme may be native or may be heterologous to the cyanobacterial cell according to the present invention. The at least one functional enzyme is preferably selected from the group consisting of GPPS from Abies grandis, Picea abies, Arabidopsis thaliana and Saccharomyces cerevisiae. More preferably, the GPPS is from Abies grandis. The enzyme may be a mutant of a prenyphosphate synthase enzyme, with specificity for forming GPP. Further, the functional enzyme may be an N- terminal truncated version of the original protein, while substantially maintaining its monoterpene synthase activity.
In a cyanobacterial cell according to the present invention, at least one functional enzyme is preferably selected from the group consisting of monoterpene synthases, which are enzymes having the ability of converting GPP to various cyclic or acyclic monoterpenes. The at least one functional enzyme may be native or may be heterologous to the cyanobacterial cell and is preferably selected from the group consisting of monoterpene synthases from Mentha spicata, Mentha Canadensis, Abies grandis, Citrus sinensis, Mentha citrata, Citrus unshiu, Thymus caespititius, Origanum vulgare and Lotus japonicas. More preferably, the monoterpene synthase is from Mentha spicata or from Mentha citrata. Further, the functional enzyme may be an N-terminal truncated version of the original protein, while substantially maintaining its monoterpene synthase activity. Preferably, at least two functional enzymes are heterologous to the cyanobacterial cell.
Preferably, a cynabacterial cell according to the present invention is capable of expressing, preferably expressing, at least one functional enzyme selected from the group of enzymes consisting of a Geranyl diphosphate synthase (GPPS) and a monoterpenes synthase (MTS), wherein the at least one functional enzyme is selected from the group consisting of GPPS from Abies grandis, Picea abies, Arabidopsis thaliana, and Saccharomyces cerevisiae; and/or wherein the at least one functional enzyme is selected from the group consisting of monoterpene synthases from Mentha spicata, Mentha Canadensis, Abies grandis, and Citrus sinensis, Mentha citrata, Citrus unshiu, Thymus caespititius, Origanum vulgare and Lotus japonicas. More preferably, the GPPS is from Abies grandis and the monoterpene synthase is from Mentha spicata or the GPPS is from Abies grandis and the monoterpene synthase is from Mentha citrata. preferred cyanobacterial cell according to the present invention is capable of producing, preferably producing, a monoterpene, preferably a monoterpene selected from the group consisting of: limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, citral, γ-terpinene, Ε-β-ocimene, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, the monoterpene is limonene or linalool; most preferably, the monoterpene is limonene. Preferably, a cyanobacterial cell according to the present invention is capable of producing, preferably producing, at least two terpenes, more preferably at least two monoterpenes. In a cyanobacterial cell according to the present invention, the at least one functional enzyme preferably comprises or consists of a polypeptide that has an amino acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26 and SEQ ID NO: 28. More preferably, the at least one functional enzyme comprises or consists of a polypeptide that has an amino acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 6 or from the group consisting of SEQ ID NO: 2 and SEQ ID NO: 18. Even more preferably, the at least one functional enzyme are at least two functional enzymes comprising or consisting of two polypeptides that have an amino acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with SEQ ID NO: 2 and SEQ ID NO: 6, or with SEQ ID NO: 2 and SEQ ID NO: 18, respectively.
In a cyanobacterial cell according to the present invention, the at least one functional enzyme is preferably encoded by a polynucleotide that has a nucleic acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91 %, 92%, 93%, 94%, 95%, 96%, 91%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 1 , SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11 , SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25 and SEQ ID NO: 27. More preferably, the at least one functional enzyme is encoded by a polynucleotide that has a nucleic acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 5 or from the group consisting of SEQ ID NO: 1 and SEQ ID NO: 17. Even more preferably, the at least one functional enzyme are at least two functional enzymes that are encoded by a polynucleotide that has a nucleic acid sequence with at least 30%, 35%, 40%, 45%, 50%, 55%, 60%, 65%, 70%, 75%, 80%, 90%, 91%, 92%, 93%, 94%, 95%, 96%, 97%, 98%, 99% or 100% sequence identity with SEQ ID NO: 1 and SEQ ID NO: 5, or with SEQ ID NO: 1 and SEQ ID NO: 17, respectively.
In the context of all embodiments of the present invention, the terms "a cyanobacterium", "a cyanobacterium cell" and "a cyanobacterial cell" are used interchangeably and refer to a blue- green algae, an oxygenic photosynthetic unicellular microorganism. Examples of cyanobacteria include the genera Aphanocapsa, Anabaena, Nostoc, Oscillatoria, Synechococcus, Synechocystis, Gloeocapsa, Agmenellum, Scytonema, Mastigocladus, Arthrosprira, and aplo siphon. A preferred order of cyanobacteria is Chroococcales. A more preferred cyanobacterium genus is Synechocystis. Synechocystis is well-studied, genetically well characterized and it does not require special media components for growth. Most importantly, it can grow mixotrophically, which means that it can grow on glucose in the absence of light. This makes Synechocystis robust for industrial applications. A more preferred strain of this genus is a Synechocystis PCC 6803 species. Even more preferably, the Synechocystis is a Pasteur Culture Collection (PCC) 6803 Synechocystis, which is a publicly available strain via ATCC for example. PCC 6803 has been stored at ATCC under ATCC27184. The phototrophic Synechocystis PCC 6803 is a fast growing cyanobacterium with no specific nutritional demands. Its physiological traits are well-documented: it is able to survive and grow in a wide range of conditions. For example, Synechocystis sp. PCC 6803 can grow in the absence of photosynthesis if a suitable fixed-carbon source such as glucose is provided. Perhaps most significantly, Synechocystis sp. PCC 6803 was the first photosynthetic organism for which the entire genome sequence was determined (available via the internet world wide web at kazusa.or.jp/cyano/cyano). In addition, an efficient gene deletion strategy (Shestakov SV et al., 2002; and Nakamura Y et al, 1999) is available for Synechocystis sp. PCC 6803, and this organism is furthermore easily transformable, also via natural transformation and homologous recombination (Grigirieva GA et al., 1982). In the context of all embodiments according to the invention, the cyanobacterium is preferably not from the genus Anabaena.
"Capable of producing monoterpene" preferably means herein that detectable amounts of monoterpene can be detected in a culture of a cyanobacterial cell according to the present invention cultured, under conditions conducive to the production of monoterpene, preferably in the presence of light and dissolved carbon dioxide and/or bicarbonate ions, during a preferred interval using a suitable assay for detecting monoterpenes. Detection may be in the culture broth (i.e. the medium including the cyanobacterial cell), in the medium or supernatant of the broth, in the cyanobacterial cell itself, and/or in the headspace of the culturing device. A preferred concentration of said dissolved carbon dioxide and/or bicarbonate ions is, the natural occurring concentration at neutral to alkaline conditions (pH 7 to 9) being approximately 1 mM. This is equivalent to 0.035% of carbon dioxide in ambient air. A more preferred concentration of carbon dioxide and/or bicarbonate ions is higher than this natural occurring concentration. Preferably, the concentration of bicarbonate ions is at least 0.5mM, 0.6mM, 0.7mM, 0.8mM, 0.9mM, lmM, 2mM, 5mM, lOmM, 15mM, 20mM, 25mM, 30mM, 35mM, 40mM, 45mM, 50mM, 60mM, 70mM, 80mM, 90mM or lOOmM. A preferred method to increase the carbon dioxide and/or bicarbonate ion concentrations in solution is by enrichment with carbon dioxide, preferably waste carbon dioxide from industrial plants, sparged into the culture broth. The concentration of carbon dioxide is preferably increased to at least 0.04%, 0.05%, 0.1%, 0.15%, 0.2%, 0.5%, 1%, 1.5%, 2%, 2.5%, 3%, 3.5%, 4%, 4.5%, or 5%.
Preferably, the monoterpene is thus detected in a cyanobacterial cell according to the present invention and/or in its culture broth or headspace, wherein said cyanobacterial cell is cultured under conditions conducive to the production of a monoterpene, preferably the conditions include culturing in the presence of sunlight and carbon dioxide during at least 1 day using a given assay for the intermediary compound.
The monoterpene produced within the cyanobacterial cell according to the invention may spontaneously diffuse into the culture broth or the headspace or both. Assays for the detection of a monoterpene are, but are not limited to, High Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Gas Chromatography-Mass Spectrometry (GC-MS), or Liquid Chromatography-Mass Spectrometry (LC-MS). A preferred assay for the detection of a monoterpene is Gas Chromatography-Mass Spectrometry (GC-MS). A detectable amount fof a monoterpene is preferably at least 1 ng/ml culture broth, 1 ng/gram dry weight of the culture broth or 1 ng/ml of culture supernatant which are preferably obtained under the culture conditions depicted here above and preferably using the above assay. Preferably, the amount is depicted as weight of product (ng, μg or mg)/gram dry weight of culture broth. Preferably, the amount is at least 2 ng, 3 ng, 4 ng, 5 ng, 6 ng, 7 ng, 8 ng, 9 ng, 10 ng, 15 ng, 20 ng, 25 ng, 30 ng, 35 ng, 40 ng, 45 ng, 50 ng, lOOng, 200ng, 300ng, 400ng, 500ng, 1 μg, 2 μg, 3 μg, 5 μg, 10 μg, 50 μg, 100 μg, 200 μg, 300 μg, 400 μg, 500 μg. lmg, 2 mg, 3 mg, 4 mg, 5 mg, 10 mg, or at least 100 mg/gram dry weight. Such amount is preferably obtained in at most 2 weeks, 1 week, 6 days, 5 days, 4 days, 3 days, 2 days, 1 day, 15 hours, 10 hours, 5 hours, 4 hours, 3 hours, 2 hours or 1 hour of culture. Preferably, a cyanobacterial cell according to the present invention comprises at least one nucleic acid molecule comprising or consisting of a polynucleotide encoding at least one of the at least one functional enzyme as defined here above. Accordingly, a preferred cyanobacterial cell according to the invention comprises at least one nucleic acid molecule comprising or consisting of a polynucleotide encoding at least one of the at least one functional enzyme as defined here above.
The at least one functional enzyme as defined here above is encoded by a polynucleotide. In all embodiments according to the invention, each encoding polynucleotide may be present on a separate nucleic acid molecule. Alternatively, the encoding polynucleotides may be present on a single nucleic acid molecule.
A preferred cyanobacterial cell according to the invention is a cyanobacterial cell wherein the at least one functional enzyme is encoded by a nucleic acid molecule comprising or consisting of a polynucleotide wherein said nucleic acid molecule is preferably present in the cyanobacterial cell as an episomal entity, preferably said episomal entity is a plasmid, more preferably a self-replicating plasmid. The episomal entity and plasmid can be any episomal entity and plasmid known to the person skilled in the art or can be based on any episomal entity and plasmid known to the person skilled in the art and modified to comprise any nucleic acid and/or polynucleotide described herein.
Another preferred cyanobacterial cell according to the invention is a cyanobacterial cell wherein the at least one functional enzyme is encoded by a nucleic acid molecule comprising or consisting of a polynucleotide wherein said nucleic acid molecule is preferably integrated in the cyanobacterial genome, preferably via homologous recombination.
A cyanobacterial cell according to the present invention may comprise a single but preferably comprises multiple copies of each nucleic acid molecule.
A preferred cyanobacterial cell according to the present invention is a cyanobacterial cell, wherein a polynucleotide encoding the at least one functional enzyme is under control of a regulatory system which responds to a change in the concentration of a nutrient when culturing said cyanobacterial cell.
A promoter that may be used for the expression of a polynucleotide encoding the at least one functional enzyme may be foreign to the polynucleotide, i.e. a promoter that is heterologous to the polynucleotide encoding the at least one functional enzyme to which it is operably linked. Although a promoter preferably is heterologous to the polynucleotide to which it is operably linked, it is also possible that a promoter is native to the cyanobacterial cell according to the present invention. Preferably, a heterologous (to the nucleotide sequence) promoter is capable of producing a higher steady state level of a transcript comprising a coding sequence (or is capable of producing more transcript molecules, i.e. mRNA molecules, per unit of time) than is a promoter that is native to the coding sequence. A suitable promoter in this context includes both constitutive and an inducible natural promoters as well as engineered promoters. A promoter used in a cyanobacterial cell according to the present invention may be modified, if desired, to affect its control characteristics. A preferred promoter for constitutive expression is a Ptrc, as is further outlined below in the next paragraph.
The Ptrc promoter is an artificial promoter, which is constructed as a chimera of the E. coli trp operon and lacUV5 promoters (Brosius et al, J Biol Chem 1985). The promoter is thus regulated by the Lac repressor, Lacl. In Synechocystis, the Lacl regulated repression and induction does not function efficiently, but the Ptrc promoter does show high constitutive expression levels in the absence of Lacl (Huang H-H, Camsund D, Lindblad P, Heidorn T: Design and characterization of molecular tools for a Synthetic Biology approach towards developing cyanobacterial biotechnology. Nucleic Acids Res 2010, 38:2577-2593).
The cyanobacterial cell according to the present invention can conveniently be used for the production of a monoterpene.
Accordingly, in a second aspect, the present invention relates to a process for producing a monoterpene comprising culturing a cyanobacterial cell according to the present invention, preferably a cyanobacterial cell as defined in the first aspect of the present invention, under conditions conducive to the production of a monoterpene and, optionally, isolating and/or purifying the monoterpene from the culture broth and/or its headspace. Said process is herein further referred to as a process according to the present invention.
Preferably, a process according to the present invention for producing a monoterpene comprises culturing a cyanobacterial cell according to the present invention, preferably a cyanobacterial cell as defined in the first aspect of the present invention, wherein the culture conditions comprise feeding carbon dioxide to the culture and/or subjecting the culture to light.
Usually, a process is started with a culture (also named culture or culture broth) of cyanobacterial cells having an optical density measured at 730 nm of approximately 0.2 to 2.0 (OD730 = 0.2 to 2) as measured in any conventional spectrophotometer with a measuring path length of 1 cm. Usually, the cell number in the culture doubles every 20 hours. A preferred process takes place in a tank with a depth of 30-50 cm exposed to sun light. Preferably, the light used is natural.
A preferred natural light is daylight, i.e. sunlight. Daylight (or sunlight) may have an intensity ranged between approximately 500 and approximately 1500 μΕίηβΐείη/ηι 2/s. In another embodiment, the light used is artificial. Such artificial light may have an intensity ranged between approximately 70 and approximately 800 μΕήΐδΐείη/ηι 2/s. Preferably, the cells are continuously under the light conditions as specified herein. However, the cells may also be exposed to high light intensities (such as e.g. daylight/sunlight) as defined elsewhere herein for a certain amount of time, after which the cells are exposed to a lower light intensity as defined elsewhere herein for a certain amount of time, and optionally this cycle is repeated. In a preferred embodiment, the cycle is the day/night cycle.
In a preferred process, the monoterpene is separated from the culture broth. This may be realized continuously with the production process or subsequently to it. Separation may be based on any separation method known to the person skilled in the art.
In a preferred process according to the present invention and in a preferred cyanobacterial cell according to the invention, the produced monoterpene is selected from the group consisting of: limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, citral, γ-terpinene, Ε-β-ocimene, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, the monoterpene is limonene, linalool, γ-terpinene or Ε-β- ocimene; even more preferably limonene or linalool; most preferably the monoterpene is limonene. In a further preferred process according to the present invention and in a preferred cyanobacterial cell according to the present invention, at least two terpenes are produced, more preferably at least two monoterpenes as described herein are produced.
The monoterpene produced by a cyanobacterial cell according to the invention and by a process according to the invention have specific properties. Accordingly, there is provided for a monoterpene obtainable by a cyanobacterial cell according to the invention and by a process according to the invention. Prefereably, such monoterpene is a monoterpene selected from the group consisting of limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, γ-terpinene, Ε-β-oc imene, citral, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, such monoterpene is a monoterpene selected from the group consisting of limonene, linalool, γ-terpinene and Ε-β-ocimene.
A monoterpene according to the invention can conveniently be used in a product. Accordingly, there is provided for a pharmaceutical composition, a fuel composition, a flavor composition, a flagrance composition or a cosmetic composition comprising a monoterpene obtainable by a cyanobacterial cell according to the invention and by a process according to the invention. Preferably, such composition comprises a monoterpene selected from the group consisting of limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, γ-terpinene, Ε-β-ocimene, citral, terpineol, myrcene, citronellol, carvone and geraniol. More preferably, such composition comprises a monoterpene selected from the group consisting of limonene, linalool, γ-terpinene and Ε-β-ocimene.
Definitions
"Sequence identity" or "identity" in the context of amino acid- or nucleic acid-sequence is herein defined as a relationship between two or more amino acid (peptide, polypeptide, or protein) sequences or two or more nucleic acid (nucleotide, polynucleotide) sequences, as determined by comparing the sequences. In the art, "identity" also means the degree of sequence relatedness between amino acid or nucleotide sequences, as the case may be, as determined by the match between strings of such sequences. Within the present invention, sequence identity with a particular sequence preferably means sequence identity over the entire length of said particular polypeptide or polynucleotide sequence. The sequence information as provided herein should not be so narrowly construed as to require inclusion of erroneously identified bases. The skilled person is capable of identifying such erroneously identified bases and knows how to correct for such errors.
"Similarity" between two amino acid sequences is determined by comparing the amino acid sequence and its conserved amino acid substitutes of one peptide or polypeptide to the sequence of a second peptide or polypeptide. In a preferred embodiment, identity or similarity is calculated over the whole SEQ ID NO as identified herein. "Identity" and "similarity" can be readily calculated by known methods, including but not limited to those described in Computational Molecular Biology, Lesk, A. M., ed., Oxford University Press, New York, 1988; Biocomputing: Informatics and Genome Projects, Smith, D. W., ed., Academic Press, New York, 1993; Computer Analysis of Sequence Data, Part I, Griffin, A. M., and Griffin, H. G., eds., Humana Press, New Jersey, 1994; Sequence Analysis in Molecular Biology, von Heine, G., Academic Press, 1987; and Sequence Analysis Primer, Gribskov, M. and Devereux, J., eds., M Stockton Press, New York, 1991; and Carillo, H., and Lipman, D., SIAM J. Applied Math., 48:1073 (1988).
Preferred methods to determine identity are designed to give the largest match between the sequences tested. Methods to determine identity and similarity are codified in publicly available computer programs. Preferred computer program methods to determine identity and similarity between two sequences include e.g. the GCG program package (Devereux, J., et al., Nucleic Acids Research 12 (1): 387 (1984)), BestFit, BLASTP, BLASTN, and FASTA (Altschul, S. F. et al, J. Mol. Biol. 215:403-410 (1990). The BLAST X program is publicly available from NCBI and other sources (BLAST Manual, Altschul, S., et al, NCBI NLM NIH Bethesda, MD 20894; Altschul, S., et al., J. Mol. Biol. 215:403-410 (1990). The well- known Smith Waterman algorithm may also be used to determine identity.
Preferred parameters for polypeptide sequence comparison include the following: Algorithm: Needleman and Wunsch, J. Mol. Biol. 48:443-453 (1970); Comparison matrix: BLOSSUM62 from Hentikoff and Hentikoff, Proc. Natl. Acad. Sci. USA. 89:10915-10919 (1992); Gap Penalty: 12; and Gap Length Penalty: 4. A program useful with these parameters is publicly available as the "Ogap" program from Genetics Computer Group, located in Madison, WI. The aforementioned parameters are the default parameters for amino acid comparisons (along with no penalty for end gaps).
Preferred parameters for nucleic acid comparison include the following: Algorithm: Needleman and Wunsch, J. Mol. Biol. 48:443-453 (1970); Comparison matrix: matches=+10, mismatch=0; Gap Penalty: 50; Gap Length Penalty: 3. Available as the Gap program from Genetics Computer Group, located in Madison, Wis. Given above are the default parameters for nucleic acid comparisons.
Optionally, in determining the degree of amino acid similarity, the skilled person may also take into account so-called "conservative" amino acid substitutions, as will be clear to the skilled person. Conservative amino acid substitutions refer to the interchangeability of residues having similar side chains. For example, a group of amino acids having aliphatic side chains is glycine, alanine, valine, leucine, and isoleucine; a group of amino acids having aliphatic-hydroxyl side chains is serine and threonine; a group of amino acids having amide- containing side chains is asparagine and glutamine; a group of amino acids having aromatic side chains is phenylalanine, tyrosine, and tryptophan; a group of amino acids having basic side chains is lysine, arginine, and histidine; and a group of amino acids having sulphur- containing side chains is cysteine and methionine. Preferred conservative amino acids substitution groups are: valine-leucine-isoleucine, phenylalanine-tyrosine, lysine-arginine, alanine-valine, and asparagine-glutamine. Substitutional variants of the amino acid sequence disclosed herein are those in which at least one residue in the disclosed sequences has been removed and a different residue inserted in its place. Preferably, the amino acid change is conservative. Preferred conservative substitutions for each of the naturally occurring amino acids are as follows: Ala to ser; Arg to lys; Asn to gin or his; Asp to glu; Cys to ser or ala; Gin to asn; Glu to asp; Gly to pro; His to asn or gin; He to leu or val; Leu to ile or val; Lys to arg; gin or glu; Met to leu or ile; Phe to met, leu or tyr; Ser to thr; Thr to ser; Trp to tyr; Tyr to trp or phe; and, Val to ile or leu.
A polynucleotide is represented by a nucleotide sequence. A polypeptide is represented by an amino acid sequence. A nnucleic acid construct is defined as a polynucleotide which is isolated from a naturally occurring gene or which has been modified to contain segments of polynucleotides which are combined or juxtaposed in a manner which would not otherwise exist in nature. Optionally, a polynucleotide present in a nucleic acid construct is operably linked to one or more control sequences, which direct the production or expression of said peptide or polypeptide in a cell or in a subject.
Polynucleotides described herein may be native or may be codon optimized. Codon optimization adapts the codon usage for an encoded polypeptide towards the codon bias of the organism where the polypeptide is to be produced in. Codon optimization generally helps to increase the production level of the encoded polypeptide in the host cell, such as in the preferred host herein: Cyanobacterium Synechocystis . Many algorithms are available to the person skilled in the art for codon optimization. A preferred method is the "guided random method based on a Monte Carlo algorithm available via the internet world wide web genomes.urv.es/OPTIMIZER/ (P. Puigbo, E. Guzman, A. Romeu, and S. Garcia- Vallve. Nucleic Acids Res. 2007 July; 35(Web Server issue): W126-W131).
A nucleotide sequence encoding an enzyme expressed or to be expressed in a cyanobacterial cell according to the invention or a promoter used in a cell according to the invention may be defined by its capability to hybridize with a nucleotide sequence such as SEQ ID NO: 1, 3, or 5 respectively, under moderate, or preferably under stringent hybridization conditions. Stringent hybridization conditions are herein defined as conditions that allow a nucleic acid sequence of at least about 25, preferably about 50 nucleotides, 75 or 100 and most preferably of about 200 or more nucleotides, to hybridize at a temperature of about 65° C. in a solution comprising about 1 M salt, preferably 6XSSC or any other solution having a comparable ionic strength, and washing at 65° C. in a solution comprising about 0.1 M salt, or less, preferably 0.2xSSC or any other solution having a comparable ionic strength. Preferably, the hybridization is performed overnight, i.e. at least for 10 hours and preferably washing is performed for at least one hour with at least two changes of the washing solution. These conditions will usually allow the specific hybridization of sequences having about 90% or more sequence identity. Moderate conditions are herein defined as conditions that allow a nucleic acid sequences of at least 50 nucleotides, preferably of about 200 or more nucleotides, to hybridize at a temperature of about 45° C. in a solution comprising about 1 M salt, preferably 6*SSC or any other solution having a comparable ionic strength, and washing at room temperature in a solution comprising about 1 M salt, preferably 6XSSC or any other solution having a comparable ionic strength. Preferably, the hybridization is performed overnight, i.e. at least for 10 hours, and preferably washing is performed for at least one hour with at least two changes of the washing solution. These conditions will usually allow the specific hybridization of sequences having up to 50% sequence identity. The person skilled in the art will be able to modify these hybridization conditions in order to specifically identify sequences varying in identity between 50% and 90%.
As used herein the term "heterologous sequence" or "heterologous nucleic acid" is one that is not naturally found operably linked as neighboring sequence of said first nucleotide sequence. As used herein, the term "heterologous" may mean "recombinant". "Recombinant" refers to a genetic entity distinct from that generally found in nature. As applied to a nucleotide sequence or nucleic acid molecule, this means that said nucleotide sequence or nucleic acid molecule is the product of various combinations of cloning, restriction and/or ligation steps, and other procedures that result in the production of a construct that is distinct from a sequence or molecule found in nature.
"Operably linked" is defined herein as a configuration in which a control sequence is appropriately placed at a position relative to the nucleotide sequence coding for the polypeptide of the invention such that the control sequence directs the production/expression of the peptide or polypeptide of the invention in a cell and/or in a subject.
"Operably linked" may also be used for defining a configuration in which a sequence is appropriately placed at a position relative to another sequence coding for a functional domain such that a chimeric polypeptide is encoded in a cell and/or in a subject.
Expression will be understood to include any step involved in the production of the peptide or polypeptide including, but not limited to, transcription, post-transcriptional modification, translation, post-translational modification and secretion.
As used herein, the term "promoter" refers to a nucleic acid fragment that functions to control the transcription of one or more nucleic acid molecules, located upstream with respect to the direction of transcription of the transcription initiation site of the nucleic acid molecule, and is structurally identified by the presence of a binding site for DNA-dependent R A polymerase, transcription initiation sites and any other DNA sequences, including, but not limited to transcription factor binding sites, repressor and activator protein binding sites, and any other sequences of nucleotides known to one of skill in the art to act directly or indirectly to regulate the amount of transcription from the promoter. A "constitutive" promoter is a promoter that is active under most environmental and developmental conditions. An "inducible" promoter is a promoter that is active under environmental or developmental regulation.
For expression of an enzyme in a cyanobacterial cell according to the inventions, as well as for additional genetic modification of a cyanobacterial cell according to the invention, the cell can be transformed with a nucleic acid or nucleic acid construct described herein by any method known to the person skilled in the art. Such methods are e.g. known from standard handbooks, such as Sambrook and Russel (2001) "Molecular Cloning: A Laboratory Manual (3rd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press, or F. Ausubel et al, eds., "Current protocols in molecular biology", Green Publishing and Wiley Interscience, New York (1987). Methods for transformation and genetic modification of cyanobacterial cells are known from e.g. U.S. Pat. No. 6,699,696 or U.S. Pat. No. 4,778,759. When a nucleic acid construct is used for expression of an enzyme in a cyanobacterial cell according to the invention, a selectable marker may be present in the nucleic acid construct comprising a polynucleotide encoding the enzyme. The term "marker" refers herein to a gene encoding a trait or a phenotype which permits the selection of, or the screening for, a cyanobacterial cell containing the marker. A marker gene may be an antibiotic resistance gene whereby the appropriate antibiotic can be used to select for transformed cells from among cells that are not transformed. Preferably however, a non-antibiotic resistance marker is used, such as an auxotrophic marker (URA3, TRP1, LEU2). A preferred cyanobacterial cell according to the invention, e.g. transformed with a nucleic acid construct, is marker gene free. Methods for constructing recombinant marker gene free microbial host cells are described in (Cheah et al., 2013) and are based on the use of bidirectional markers. Alternatively, a screenable marker such as Green Fluorescent Protein, lacZ, luciferase, chloramphenicol acetyltransferase, beta-glucuronidase may be incorporated into a nucleic acid construct according to the invention allowing to screen for transformed cells.
Optional further elements that may be present in a nucleic acid construct according to the invention include, but are not limited to, one or more leader sequences, enhancers, integration factors, and/or reporter genes, intron sequences, centromers, telomers and/or matrix attachment (MAR) sequences. A nucleic acid construct according to the invention can be provided in a manner known per se, which generally involves techniques such as restricting and linking nucleic acids/nucleic acid sequences, for which reference is made to the standard handbooks, such as Sambrook and ussel (2001) "Molecular Cloning: A Laboratory Manual (3rd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press.
Methods for inactivation and gene disruption in a cyanobacterial cell are well known in the art (see e.g. Shestakov S V et al, (2002), Photosynthesis Research, 73 : 279-284 and Nakamura Y et al, (1999), Nucleic Acids Res. 27:66-68).
In this document and in its claims, the verb "to comprise" and its conjugations is used in its non- limiting sense to mean that items following the word are included, but items not specifically mentioned are not excluded. In addition, reference to an element by the indefinite article "a" or "an" does not exclude the possibility that more than one of the element is present, unless the context clearly requires that there be one and only one of the elements. The indefinite article "a" or "an" thus usually means "at least one".
The word "about" or "approximately" when used in association with a numerical value (e.g. about 10) preferably means that the value may be the given value (of 10) more or less 0.1% of the value.
The sequence information as provided herein should not be so narrowly construed as to require inclusion of erroneously identified bases. The skilled person is capable of identifying such erroneously identified bases and knows how to correct for such errors. In case of sequence errors, the sequence of the enzymes obtainable by expression of the genes as represented by SEQ ID NO's 1, 3, 5, 7, 9, 1 1, 13, 15, 17, 19, 21 , 23, 25 and 27 containing the enzyme encoding polynucleotide sequences should prevail.
All patent and literature references cited in the present specification are hereby incorporated by reference in their entirety. Table 2. Sequences
SEQ ID Gene/Polypeptide Sequence
NO
1 geranyl ATGGCTTACAGTGCTATGGCAACCATGGGTTACAAT diphosphate GGTATGGCAGCTAGCTGCCATACCCTGCATCCTACC synthase from AGCCCATTAAAACCTTTTCATGGAGCTTCAACCTCA Abies grandis CTGGAAGCTTTTAATGGCGAGCATATGGGCCTCCTC
CGAGGGTATTCGAAGAGGAAGCTATCTTCATATAAA
AATCCGGCATCTAGATCCTCAAACGCTACAGTTGCC
CAGTTGCTTAATCCTCCACAAAAAGGGAAGAAGGC
CGTTGAATTTGATTTCAACAAGTACATGGATTCCAA
GGCAATGACAGTGAATGAGGCGTTGAATAAGGCTA TCCCACTTCGTTATCCCCAGAAAATATATGAATCCA
TGAGGTATTCTCTTCTGGCAGGAGGGAAACGAGTTC
GTCCTGTTCTGTGCATTGCAGCATGTGAGCTTGTTG
GAGGAACCGAGGAGCTTGCGATTCCAACTGCCTGTG
CAATCGAAATGATCCACACAATGTCTTTGATGCATG
ATGACTTGCCTTGCATAGACAATGATGATTTACGGC
GAGGGAAACCTACAAACCATAAGATCTTCGGGGAA
GATACTGCTGTTACTGCAGGGAATGCGCTTCATTCT
TACGCCTTTGAGCATATTGCAGTTTCCACAAGCAAA
ACTGTGGGGGCTGATAGGATTTTGAGGATGGTATCT
GAACTGGGTAGAGCAACAGGCTCTGAAGGGGTTAT
GGGTGGCCAGATGGTCGATATTGCCAGCGAAGGGG
ATCCTTCTATTGACCTTCAGACTCTGGAATGGATTC
ATATTCACAAGACTGCAATGCTCTTGGAGTGCTCGG
TTGTGTGTGGGGCGATCATCGGTGGTGCTTCGGAGA
TTGTGATCGAGAGAGCTCGAAGGTATGCCCGTTGCG
TGGGGCTTCTTTTTCAGGTTGTGGATGACATACTCG
ATGTCACGAAATCATCAGACGAACTGGGCAAGACT
GCAGGAAAGGATTTGATTAGTGATAAGGCAACTTAT
CCAAAGCTCATGGGTTTGGAGAAAGCAAAGGAGTT
TTCTGATGAATTGTTGAACAGAGCTAAGGGAGAGTT
ATCTTGCTTCGATCCAGTGAAGGCAGCACCTCTGTT
GGGTCTTGCAGATTACGTGGCATTCAGACAAAATTG
A
geranyl MA YS AM ATMGY GM AAS CHTLHPT SPLKPFHG ASTS diphosphate LEAFNGEHMGLLRGYSKRKLSSYKNPASRSSNATVAQ synthase from LLNPPQKGKKAVEFDF KYMDSKAMTV EALNKAIP Abies grandis LRYPQKIYESMRYSLLAGGKRVRPVLCIAACELVGGT
EELAIPTACAIEMIHTMSLMHDDLPCIDNDDLRRGKPT
NHKIFGEDTAVTAGNALHSYAFEHIAVSTSKTVGADPJ
LRMVSELGRATGSEGVMGGQMVDIASEGDPSIDLQTL
EWIHIHKTAMLLECSVVCGAIIGGASEIVIERARRYARC
VGLLFQVVDDILDVTKSSDELGKTAGKDLISDKATYP
KLMGLEKAKEFSDELLNRAKGELSCFDPVKAAPLLGL
ADYVAFRQN
farnesyl ATGGCTTCAGAAAAAGAAATTAGGAGAGAGAGATT diphosphate CTTGAACGTTTTCCCTAAATTAGTAGAGGAATTGAA synthase from CGCATCGCTTTTGGCTTACGGTATGCCTAAGGAAGC
Saccharomyces ATGTGACTGGTATGCCCACTCATTGAACTACAACAC cerevisiae
TCCAGGCGGTAAGCTAAATAGAGGTTTGTCCGTTGT GGACACGTATGCTATTCTCTCCAACAAGACCGTTGA ACAATTGGGGCAAGAAGAATACGAAAAGGTTGCCA TTCTAGGTTGGTGCATTGAGTTGTTGCAGGCTTACTT CTTGGTCGCCGATGATATGATGGACAAGTCCATTAC
CAGAAGAGGCCAACCATGTTGGTACAA
GGTTCCTGAAGTTGGGGAAATTGCCATCAATGACGC
ATTCATGTTAGAGGCTGCTATCTACAAGCTTTTGAA
ATCTCACTTCAGAAACGAAAAATACTACATAGATAT
CACCGAATTGTTCCATGAGGTCACCTTCCAAACCGA
ATTGGGCCAATTGATGGACTTAATCACTGCACCTGA
AGACAAAGTCGACTTGAGTAAGTTCTCCCTAAAGAA
GCACTCCTTCATAGTTACTTTCAAGACTGCTTACTAT
TCTTTCTACTTGCCTGTCGCATTGGCCATGTACGTTG
CCGGTATCACGGATGAAAAGGATTTGAAACAAGCC
AGAGATGTCTTGATTCCATTGGGTG
AATACTTCCAAATTCAAGATGACTACTTAGACTGCT
TCGGTACCCCAGAACAGATCGGTAAGATCGGTACA
GATATCCAAGATAACAAATGTTCTTGGGTAATCAAC
AAGGCATTGGAACTTGCTTCCGCAGAACAAAGAAA
GACTTTAGACGAAAATTACGGTAAGAAGGACTCAG
TCGCAGAAGCCAAATGCAAAAAGATTTTCAATGACT
TGAAAATTGAACAGCTATACCACGAATATGAAGAG
TCTATTGCCAAGGATTTGAAGGCCAAAATTTCTCAG
GTCGATGAGTCTCGTGGCTTCAAAGCTGATGTCTTA
ACTGCGTTCTTGAACAAAGTTTACAAGAGA
AGCAAATAG
farnesyl MASEKEIRRERFLNVFPKLVEELNASLLAYGMPKEAC diphosphate DWYAHSLNY TPGGKLNRGLSVVDTYAILSNKTVEQ synthase from LGQEEYEKVAILGWCIELLQAYFLVADDMMDKSITRR
Saccharomyces GQPCWYKVPEVGEIAINDAFMLEAAIYKLLKSHFRNE cerevisiae
KYYIDITELFHEVTFQTELGQLMDLITAPEDKVDLSKFS
LKKHSFIVTFKTAYYSFYLPVALAMYVAGITDEKDL
QARDVLIPLGEYFQIQDDYLDCFGTPEQIG IGTDIQDN
KCSWVIN ALELASAEQRKTLDENYGKKDSVAEAKC
KKIFNDLKIEQLYHEYEESIAKDLKAKISQVDESRGFK
ADVLTAFLNKVYKRSK
4S-limonene ATGGCTCTCAAAGTGTTAAGTGTTGCAACTCAAATG synthase from GCGATTCCTAGCAACCTAACGACATGTCTTCAACCC Mentha spicata TCACACTTCAAATCTTCTCCAAAACTGTTATCTAGC
ACTAACAGTAGTAGTCGGTCTCGCCTCCGTGTGTAT
TGCTCCTCCTCGCAACTCACTACTGAAAGACGATCC
GGAAACTACAACCCTTCTCGTTGGGATGTCAACTTC
ATCCAATCGCTTCTCAGTGACTATAAGGAGGACAAA
CACGTGATTAGGGCTTCTGAGCTGGTCACTTTGGTG
AAGATGGAACTGGAGAAAGAAACGGATCAAATTCG
ACAACTTGAGTTGATCGATGACTTGCA GAGGATGGGGCTGTCCGATCATTTCCAAAATGAGTT
CAAAGAAATCTTGTCCTCTATATATCTCGACCATCA
CTATTACAAGAACCCTTTTCCAAAAGAAGAAAGGG
ATCTCTACTCCACATCTCTTGCATTTAGGCTCCTCAG
AGAACATGGTTTTCAAGTCGCACAAGAGGTATTCGA
TAGTTTCAAGAACGAGGAGGGTGAGTTCAAAGAAA
GCCTTAGCGACGACACCAGAGGATTGTTGCAACTGT
ATGAAGCTTCCTTTCTGTTGACGGAAGGCGAAACCA
CGCTCGAGTCAGCGAGGGAATTCGCCACCAAATTTT
TGGAGGAAAAAGTGAACGAGGGTGGTG
TTGATGGCGACCTTTTAACAAGAATCGCATATTCTT
TGGACATCCCTCTTCATTGGAGGATTAAAAGGCCAA
ATGCACCTGTGTGGATCGAATGGTATAGGAAGAGG
CCCGACATGAATCCAGTAGTGTTGGAGCTTGCCATA
CTCGACTTAAATATTGTTCAAGCACAATTTCAAGAA
GAGCTCAAAGAATCCTTCAGGTGGTGGAGAAATAC
TGGGTTTGTTGAGAAGCTGCCCTTCGCAAGGGATAG
ACTGGTGGAATGCTACTTTTGGAATACTGGGATCAT
CGAGCCACGTCAGCATGCAAGTGCAAGGATAATGA
TGGGCAAAGTCAACGCTCTGATTACGGTG
ATCGATGATATTTATGATGTCTATGGCACCTTAGAA
GAACTCGAACAATTCACTGACCTCATTCGAAGATGG
GATATAAACTCAATCGACCAACTTCCCGATTACATG
CAACTGTGCTTTCTTGCACTCAACAACTTCGTCGAT
GATACATCGTACGATGTTATGAAGGAGAAAGGCGT
CAACGTTATACCCTACCTGCGGCAATCGTGGGTTGA
TTTGGCGGATAAGTATATGGTAGAGGCACGGTGGTT
CTACGGCGGGCACAAACCAAGTTTGGAAGAGTATTT
GGAGAACTCATGGCAGTCGATAAGTGGGCCCTGTAT
GTTAAC GC AC AT ATTCTTC CGAGT AAC
AGATTCGTTCACAAAGGAGACCGTCGACAGTTTGTA
CAAATACCACGATTTAGTTCGTTGGTCATCCTTCGTT
CTGCGGCTTGCTGATGATTTGGGAACCTCGGTGGAA
GAGGTGAGCAGAGGGGATGTGCCGAAATCACTTCA
GTGCTACATGAGTGACTACAATGCATCGGAGGCGG
AGGCGCGGAAGCACGTGAAATGGCTGATAGCGGAG
GTGTGGAAGAAGATGAATGCGGAGAGGGTGTCGAA
GGATTCTCCATTCGGCAAAGATTTTATAGGATGTGC
AGTTGATTTAGGAAGGATGGCGCAGTTGATGTACCA
TAATGGAGATGGGCACGGCACACAACACC
CTATTATACATCAACAAATGACCAGAACCTTATTCG
AGCCCTTTGCATGA
4S-limonene MALKVLS VATQMAIPSNLTTCLQPSHFKS SPKLLS STN synthase from Mentha spicata SSSRSRLRVYCSSSQLTTERRSGNYNPSRWDVNFIQSL
LSDYKEDKHVIRASELVTLVKMELEKETDQIRQLELID
DLQRMGLSDHFQNEFKEILSSIYLDHHYYK PFP EER
DLYSTSLAFRLLREHGFQVAQEVFDSFKNEEGEFKESL
SDDTRGLLQLYEASFLLTEGETTLESAREFATKFLEE
VNEGGVDGDLLTRIAYSLDIPLHWRIKRPNAPVWIEW
YRKRPDMNPVVLELAILDLNIVQAQFQEELKESFRWW
RNTGFVEKLPFARDRLVECYFWNTGIIEPRQHASARIM
MGKVNALITVIDDIYDVYGTLEELEQFTDLIRRDINSID
QLPDYMQLCFLALNNFVDDTSYDVMKEKGVNVIPYL
RQSWVDLADKYMVEARWFYGGHKPSLEEYLENSWQ
SISGPCMLTHIFFRVTDSFTKETVDSLYKYHDLVRWSS
FVLRLADDLGTSVEEVSRGDVPKSLQCYMSDY ASEA
EARKHVKWLIAEVWKKMNAERVSKDSPFGKDFIGCA
VDLGRMAQLMYHNGDGHGTQHPIIHQQMTRTLFEPF
A
geranyl ATGGGTTACAATGGCATGGTAGTTAGCTCCAACCTT diphosphate GGCCTGTATTATTTGAACATTGCCTCTCGAGAAT synthase from GTAACCTGAAAAGAATTTCAATCCCATCACCTTTTC Picea abies ATGGCGTTTCAACCTCATTGGGCTCTTCTACTAG
TAAACATCTGGGCCTCCGTGGCCATTTGAAGAAAGA
GTTGTTGTCACATAGACTTCTGCTATCATCAACT
AGATCGTCGAAAGCACTTGTCCAGCTAGCTGATCTG
TCTGAACAGGTGAAGAATGTTGTTGAGTTTGATT
TCGATAAGTACATGCATTCCAAGGCAATTGCAGTGA
ATGAGGCATTGGATAAGGTTATCCCACCACGTTA
TCCCCAGAAAATATATGAATCCATGAGGTATTCTCT
TCTAGCAGGAGGGAAACGAGTTCGTCCTATTTTG
TGCATTGCTGCGTGCGAGCTTATGGGAGGAACCGAG
GAGCTTGCGATGCCAACTGCCTGTGCAATTGAAA
TGATCCACACAATGTCTTTGATTCATGATGACTTGC
CTTACATAGACAATGATGATTTACGCCGAGGGAA
GCCCACAAACCATAAGGTCTTCGGGGAGGATACTG
CTATTATTGCAGGGGATGCACTTCTTTCACTCGCC
TTTGAACACGTTGCAGTCTCCACGAGCAGAACTCTG
GGGACTGATATAATTTTGAGGCTGCTATCTGAAA
TCGGTAGAGCAACAGGCTCTGAAGGGGTTATGGGT
GGCCAGGTTGTCGATATCGAGAGCGAAGGCGATCC
TTCTATTGATCTCGAGACTCTCGAATGGGTTCATATT
CACAAGACTGCAGTGCTCTTGGAGTGCTCGGTT
GTGTGTGGGGCGATCATGGGTGGTGCTTCGGAGGAT
GATATTGAGAGAGCTCGAAGGTATGCCCGTTGCG
TGGGGCTTCTGTTTCAGGTTGTGGATGACATACTCG ATGTCTCTCAATCATCAGAAGAATTGGGCAAGAC
GGCAGGGAAGGATTTGATTAGTGATAAAGCCACTT
ATCCCAAGCTGATGGGTTTGGAGAAAGCAAAGGAA
TTTGCTGATGAATTGTTGAACAGAGGTAAGCAGGAG
TTATCTTGCTTCGACCCAACTAAGGCTGCACCTT
TGTTTGCTCTGGCAGATTACATTGCTTCAAGACAAA
ACTGA
geranyl MGY GMVVSSNLGLYYLNIASRECNLKRISIPSPFHGV diphosphate STSLGSSTSKHLGLRGHLKKELLSHRLLLSSTRSSKAL synthase from VQLADLSEQVKNVVEFDFDKYMHSKAIAVNEALDKV Picea abies IPPRYPQKIYESMRYSLLAGGKRVRPILCIAACELMGG
TEELAMPTACAIEMIHTMSLIHDDLPYIDNDDLRRGKP
TNHKVFGEDTAIIAGDALLSLAFEHVAVSTSRTLGTDII
LRLLSEIGRATGSEGVMGGQVVDIESEGDPSIDLETLE
WVHIH T AVLLEC S VVC GAIMGGASEDDIERARRY AR
CVGLLFQVVDDILDVSQSSEELGKTAGKDLISDKATYP
KLMGLEKAKEFADELLNRGKQELSCFDPTKAAPLFAL
ADYIASRQN
geranyl ATGTTATTCACGAGGAGTGTTGCTCGGATTTCTTCTA diphosphate AGTTTCTGAGAAACCGTAGCTTCTATGGCTCCT synthase from CTCAATCTCTCGCCTCTCATCGGTTCGCAATCATTCC Arabidopsis CGATCAGGGTCACTCTTGTTCTGACTCTCCACA thaliana
CAAGGGTTACGTTTGCAGAACAACTTATTCATTGAA
ATCTCCGGTTTTTGGTGGATTTAGTCATCAACTC
TATCACCAGAGTAGCTCCTTGGTTGAGGAGGAGCTT
GACCCATTTTCGCTTGTTGCCGATGAGCTGTCAC
TTCTTAGTAATAAGTTGAGAGAGATGGTACTTGCCG
AGGTTCCAAAGCTTGCCTCTGCTGCTGAGTACTT
CTTCAAAAGGGGTGTGCAAGGAAAACAGTTTCGTTC
AACTATTTTGCTGCTGATGGCGACAGCTCTGGAT
GTACGAGTTCCAGAAGCATTGATTGGGGAATCAAC
AGATATAGTCACATCAGAATTACGCGTAAGGCAAC
GGGGTATTGCTGAAATCACTGAAATGATACACGTCG
CAAGTCTACTGCACGATGATGTCTTGGATGATGC
CGATACAAGGCGTGGTGTTGGTTCCTTAAATGTTGT
AATGGGTAACAAGATGTCGGTATTAGCAGGAGAC
TTCTTGCTCTCCCGGGCTTGTGGGGCTCTCGCTGCTT
TAAAGAACACAGAGGTTGTAGCATTACTTGCAA
CTGCTGTAGAACATCTTGTTACCGGTGAAACCATGG
AGATAACTAGTTCAACCGAGCAGCGTTATAGTAT
GGACTACTACATGCAGAAGACATATTATAAGACAG
CATCGCTAATCTCTAACAGCTGCAAAGCTGTTGCC
GTTCTCACTGGACAAACAGCAGAAGTTGCCGTGTTA GCTTTTGAGTATGGGAGGAATCTGGGTTTAGCAT
TCCAATTAATAGACGACATTCTTGATTTCACGGGCA
CATCTGCCTCTCTCGGAAAGGGATCGTTGTCAGA
TATTCGCCATGGAGTCATAACAGCCCCAATCCTCTT
TGCCATGGAAGAGTTTCCTCAACTACGCGAAGTT
GTTGATCAAGTTGAAAAAGATCCTAGGAATGTTGAC
ATTGCTTTAGAGTATCTTGGGAAGAGCAAGGGAA
TACAGAGGGCAAGAGAATTAGCCATGGAACATGCG
AATCTAGCAGCAGCTGCAATCGGGTCTCTACCTGA
AACAGACAATGAAGATGTCAAAAGATCGAGGCGGG
CACTTATTGACTTGACCCATAGAGTCATCACCAGA
AACAAGTGA
geranyl MLFTRSVARISSKFLRNRSFYGSSQSLASHRFAIIPDQG diphosphate HSCSDSPH GYVCRTTYSLKSPVFGGFSHQL synthase from YHQSSSLVEEELDPFSLVADELSLLSNKLREMVLAEVP Arabidopsis KLASAAEYFFKRGVQGKQFRSTILLLMATALD thaliana
VRVPEALIGESTDIVTSELRVRQRGIAEITEMIHVASLL
HDDVLDDADTRRGVGSLNVVMGNKMSVLAGD
FLLSRACGALAALK TEVVALLATAVEHLVTGETMEI
TSSTEQRYSMDYYMQKTYYKTASLISNSCKAVA
VLTGQTAEVAVLAFEYGR LGLAFQLIDDILDFTGTSA
SLG GSLSDIRHGVITAPILFAMEEFPQLREV
VDQVEKX)PRNVDIALEYLG SKGIQRARELAMEHANL
AAAAIGSLPETDNEDVKRSRRALIDLTHRVITR
NK
limonene synthase ATGGCTCTCAAAGTGTTAAGTGTTGCAACTCAAATG from Mentha GCGATTCCTAGCAAGCTAACGAGATGTCTTCAAC canadensis CCTCACACTTGAAATCCTCTCCAAAATTGTTATCTA
GCACTAACAGTAGTAGTCGGTCTCGCCTCCGTGT
GTATTGCTCCTCCTCGCAACTCACTACTGAGAGACG
ATCCGGAAACTACAACCCTTCTCGTTGGGATGTC
GAATTCATCCAATCCCTCCACAGTGATTATGAGGAG
GACAAACATGCGATTAGGGCTTCTGAGCTGGTCA
CTTTGGTGAAGATGGAATTGGAGAAAGAAACGGAT
CATATTCGACAACTTGAGTTGATCGATGACTTGCA
GAGGATGGGGCTGTCCGATCATTTCCAGAATGAGTT
CAAAGAAATCTTGTCCTCTATATATCTCGACCAT
CACTATTACAAGAACCCTTTTCCAGAAGAAGAAAA
GGGATCTCTACTCACATCTCTTGCATTTAGGCTCC
TCAGAGAACATGGTTTTCAAGTCGCACAAGAGGTAT
TCGACAGTTTCAAGAACGAGGAGGGTGAGTTCAA
AGAAAGCCTTAGCGACGACACTAGAGGATTGTTGC
GACTGTATGAAGCTTCCTTTCTGTTGACGGAAGGC GAAACCACGCTCGAGTCAGCGAGGGAATTCGCCAC
CAAATTTTTGGAGGAAAGAGTGAACGAGGGTGGTG
TTGATGGCGACCTTTTAACAAGAATCGCATATTCTT
TGGACATCCCACTTCATTGGAGGATTAAAAGGCC
AAATGCACCTACGTGGATCGAATGGTATAGGAAGA
GGCCCGACATGAATCCAGTAGTGTTGGAGCTTGCC
ATACTCGACTTAGATATTGTTCAAGCACAATTTCAA
GAAGAGCTCAAAGAATCCTTCAGGTGGTGGAGAA
ATACTGGTTTTGTTGAGAAGCTGCCCTTCGCAAGGG
ATAGATTGGTGGAATGCTACTTTTGGAATACTGG
GATCATCGAGCCACGTCAGCATGCAAGTGCAAGGA
TAATGATGGGCAAAGTCAACGCTCTGATTACGGTG
ATCGATGATATTTATGATGTCTACGGCACCTTAGAA
GAACTCGAACAATTCACAGAACTCATTCGGAGAT
GGGATATAAACTCAATCGACCAACTTCCCGATTACA
TGCAACTGTGCTTTCTTGCACTCAACAACTTCGT
CGATGATACATCGTACGATGTTATGAAGGAGAAAG
GCGTCAACGTTATACCCTACCTGCGGCAATCGTGG
GTGGATTTGGCGGATAAGTATATGGTAGAGGCACG
GTGGTTCTACGGCGGGCACAAACCAAGTTTGGAAG
AGTATTTGGAGAACTCATGGCAGTCGATAAGTGGGC
CCTGTATGTTAACGCACATATTCTTCCGAGTAAC
AGATTCGTTCACAAAGGAGACCGTCGACAGCTTGTA
CAAATACCACGATTTAGTTCGTTGGTCGTCCTTC
GTTCTGCGGCTTGCTGATGATTTGGGAACCTCGGTG
GAAGAGGTGAGCAGAGGCGATGTGCCGAAATCAC
TTCAGTGCTACATGAGTGACTACAATGCATCGGAGG
CGGAGGCGCGGAAGCACGTGAAATGGCTGATAGC
GGAGGTGTGGAAGAAGATGAATGCGGAGAGGGTGC
CGAAGGATTCTCCATTCGGCAAAGATTTTATAGGA
TGTGCAGCTGATTTAGGAAGGATGGCGCAGTTGATG
TACCATAATGGAGATGGGCACGGCACACAACATC
CT AT AATAC ATC AAC AAATGAC C AG AAC CTTATTC G
AGCCCTTTGCATGA
limonenc synthase MALKVLSVATQMAIPSKLTRCLQPSHLKSSPKLLSSTN from Mentha S S SPvSPvLRVYC S S S QLTTERRSGNYNPSRWD V canadensis EFIQSLHSDYEEDKHAIRASELVTLVKMELEKETDHIR
QLELIDDLQRMGLSDHFQNEFKEILS SIYLDH
HYYK PFPEEE GSLLTSLAFRLLREHGFQVAQEVFDS
FK EEGEF ESLSDDTRGLLRLYEASFLLTEG
ETTLESAREFATKFLEERV EGGVDGDLLTRIAYSLDIP
LHWRIKRPNAPTWIEWYRKRPDMNPVVLELA
ILDLDIVQAQFQEELKESFRWWRNTGFVEKLPFARDR LVECYFW TGIIEPRQHASARIMMGKVNALITV
IDDIYDVYGTLEELEQFTELIRRWDINSIDQLPDYMQLC
FLAL F VDDT S YD VMKEKGV VIP YLRQ S W
VDLAD YMVEARWFYGGHKPSLEEYLENSWQSISGP
CMLTHIFFRVTDSFTKETVDSLY YHDLVRWSSF
VLRLADDLGTSVEEVSRGDVP SLQCYMSDYNASEAE
ARKHVKWLIAEVWKKMNAERVPKDSPFGKDFIG
CAADLGRMAQLMYHNGDGHGTQHPIIHQQMTRTLFE
PFA
4S-limonene ATGGCTCTCCTTTCTATCGTATCTTTGCAGGTTCCCA synthase from AATCCTGCGGGCTGAAATCGTTGATCAGTTCCA Abies grandis GCAATGTGCAGAAGGCTCTCTGTATCTCTACAGCAG
TCCCAACACTCAGAATGCGTAGGCGACAGAAAGC
TCTGGTCATCAACATGAAATTGACCACTGTATCCCA
TCGTGATGATAATGGTGGTGGTGTACTGCAAAGA
CGCATAGCCGATCATCATCCCAACCTGTGGGAAGAT
GATTTCATACAATCATTGTCCTCACCTTATGGGG
GATCTTCGTACAGTGAACGTGCTGAGACAGTCGTTG
AGGAAGTAAAAGAGATGTTCAATTCAATACCAAA
TAATAGAGAATTATTTGGTTCCCAAAATGATCTCCT
TACACGCCTTTGGATGGTGGATAGCATTGAACGT
CTGGGGATAGATAGACATTTCCAAAATGAGATAAG
AGTAGCCCTCGATTATGTTTACAGTTATTGGAAGG
AAAAGGAAGGCATTGGGTGTGGCAGAGATTCTACT
TTTCCTGATCTCAACTCGACTGCCTTGGCGCTTCG
AACTCTTCGACTGCACGGATACAATGTGTCTTCAGA
TGTGCTGGAATACTTCAAAGATGAAAAGGGGCAT
TTTGCCTGCCCTGCAATCCTAACCGAGGGACAGATC
ACTAGAAGTGTTCTAAATTTATATCGGGCTTCCC
TGGTCGCCTTTCCCGGGGAGAAAGTTATGGAAGAG
GCTGAAATCTTCTCGGCATCTTATTTGAAAAAAGT
CTTACAAAAGATTCCGGTCTCCAATCTTTCAGGAGA
GATAGAATATGTTTTGGAATATGGTTGGCACACG
AATTTGCCGAGATTGGAAGCAAGAAATTATATCGA
GGTCTACGAGCAGAGCGGCTATGAAAGCTTAAACG
AGATGCCATATATGAACATGAAGAAGCTTTTACAAC
TTGCAAAATTGGAGTTCAATATCTTTCACTCTTT
GCAACTAAGAGAGTTACAATCTATCTCCAGATGGTG
GAAAGAATCAGGTTCGTCTCAACTGACTTTTACA
CGGCATCGTCACGTGGAATACTACACTATGGCATCT
TGCATTTCTATGTTGCCAAAACATTCAGCTTTCA
GAATGGAGTTTGTCAAAGTGTGTCATCTTGTAACAG
TTCTCGATGATATATATGACACTTTTGGAACAAT GAACGAACTCCAACTTTTTACGGATGCAATTAAGAG
ATGGGATTTGTCAACGACAAGGTGGCTTCCAGAA
TATATGAAAGGAGTGTACATGGACTTGTATCAATGC
ATTAATGAAATGGTGGAAGAGGCTGAGAAGACTC
AAGGCCGAGATATGCTCAACTATATTCAAAATGCTT
GGGAAGC CCT ATTTGATAC CTTTATGC AAGAAGC
AAAGTGGATCTCCAGCAGTTATCTCCCAACGTTTGA
GGAGTACTTGAAGAATGCAAAAGTTAGTTCTGGT
TCTCGCATAGCCACATTACAACCCATTCTCACTTTG
GATGTACCACTTCCTGATTACATACTGCAAGAAA
TTGATTATCCATCCAGATTCAATGAGTTAGCTTCGTC
CATCCTTCGACTACGAGGTGACACGCGCTGCTA
CAAGGCGGATAGGGCCCGTGGAGAAGAAGCTTCAG
CTATATCGTGTTATATGAAAGACCATCCTGGATCA
ATAGAGGAAGATGCTCTCAATCATATCAACGCCATG
ATCAGTGATGCAATCAGAGAATTAAATTGGGAGC
TTCTCAGACCGGATAGCAAAAGTCCCATCTCTTCCA
AGAAACATGCTTTTGACATCACCAGAGCTTTCCA
TCATGTCTACAAATATCGAGATGGTTACACTGTTTC
CAACAACGAAACAAAGAATTTGGTGATGAAAACC
GTTCTTGAACCTCTCGCTTTGTAA
4S-iimonenc MALLSIVSLQVPKSCGLKSLISSSNVQKALCISTAVPTL synthase from RMRRRQKA.LVINMKLTTVSHRDDNGGGVLQR Abies grandis PJADHHPNL WEDDFIQ SLS SPYGGSS YSERAETVVEEV
KEMFNSIP NRELFGSQNDLLTRLW VDSIER
LGIDRHFQNEIRVALDYVYSYWKEKEGIGCGRDSTFP
DLNSTALALRTLRLHGY VSSDVLEYFKDEKGH
FACPAILTEGQITRSVLNLYRASLVAFPGEKVMEEAEIF
S AS YLKKVLQKIPV SNL S GEIEYVLEYG WHT
NLPRLE AR YIEVYEQS GYE SLNEMP YMNMKKLLQL
AKLEFNIFHSLQLRELQSISRWWKESGSSQLTFT
RHRHVEYYTMASCISMLPKHSAFRMEFV VCHLVTV
LDDIYDTFGTMNELQLFTDAIKRWDLSTTRWLPE
YMKGVYMDLYQCINEMVEEAE TQGRDMLNYIQNA
WE ALFDTFMQEA WIS S SYLPTFEEYLKNAKVS SG
SRIATLQPILTLDVPLPDYILQEIDYPSRFNELASSILRLR
GDTRCYKADRARGEEASAISCYMKDHPGS
IEED ALNHrNAMI SD AIRELN WELLRPD S SPI S SKKHA
FDITRAFHHVY YRDGYTVS ETKNLVMKT
VLEPLAL
R-limonene ATTTGAGAATCTTTGCCAAGTATAACTGTAAGCTAG synthase from CTTACACTACATCTGTATATCCAATGTCTTCTTG Citrus sinensis CATTAATCCCTCAACCTTGGTTACCTCTATAAATGGT TTCAAATGTCTTCCTCTTGCAACAAATAAAGCA
GCCATCAGAATCATGGCCAAAAATAAGCCAGTCCA
ATGCCTTGTCAGCGCCAAATATGATAATTTGACAG
TTGATAGGAGATCAGCAAACTACCAACCTTCAATTT
GGGACCATGATTTTTTGCAGTCATTGAATAGCAA
CTATACGGATCAAACATACAGAAGACGAGCAGAAG
AGCTGAAGGGAAAAGTGAAGACAGCGATTAAGGAT
GTAACCGAGCCTCTGGATCAGTTGGAGCTGATTGAC
AACTTGCAAAGACTTGGATTGGCTTATCATTTTG
AGACTGAGATTCGAAACATATTGCATAATATCTACA
ACAATAATAAAGATTATATTTGGAGAAAAGCAAA
TCTGTATGCAACCTCCCTTGAATTCAGACTACTTAG
ACAACATGGCTATCCTGTTTCTCAAGAGGTTTTC
AGTGGTTTTAAAGACGACAAGGGAGGCTTCATTTGT
GATGATTTCAAGGGAATACTGAGCTTGCATGAAG
CCTCGTATTACAGCTTAGAAGGAGAAAGCATCATGG
AGGAGGCCTGGCAATTCACCAGTAAGCATCTTAA
AGAAAC GATG ATC ATC AGC AAC AGC AAGGAAGAGT
ATGTATTTGTAGCAGAACAAGCGAAGCGTGCGCTG
GAGCTCCCTCTGCATTGGAAAGTGCCAACGTTGGAG
GCAAGGTGGTTCATACACGTTTATGAGAAAAGAG
AGGACAAGAACCACCTTTTACTTGAGCTCGCTAAGT
TGGAGTTTAACACTTTGCAGGCAATTTACCAGGA
AGAACTTAAAGACATTTCAGGATGGTGGAAGGATA
CAGGTCTTGGAGAGAAATTGAGCTTTGCGAGGAAC
AGGTTGGTAGCGTCCTTCTTATGGAGCATGGGGATC
GCGTTTGAGCCTCAATTCGCCTACTGCAGGAGAG
TGCTCACAATCTCGATAGCCCTAATTACAGTGATTG
ATGACATTTATGATGTCTATGGAACATTGGATGA
ACTTGAGATATTCACTGATGCTGTTGCGAGGTGGGA
CATCAATTATGCTTTGAAGCACCTTCCGGGATAT
ATGAAAATGTGTTTTCTTGCGCTTTACAACTTTGTTA
ATGAATTTGCTTATTACGTTCTCAAACAACAGG
ATTTTGATATGCTTCTGAGCATAAAAAATGCATGGC
TTGGCTTAATACAAGCCTACTTGGTGGAGGCGAA
ATGGTACCATAGCAAGTACACACCGAAACTGGAAG
AATACTTGGAAAATGGATTGGTGTCAATAACGGGC
CCTTTAATTATAGCGATTTCATATCTTTCTGGTACAA
ATCCAATCATTAAGAAGGAACTGGAATTTCTAG
AAAGTAATCCAGATATAGTTCACTGGTCATCCAAGA
TTTTCCGTCTGCAAGATGATTTGGGAACTTCATC
GGACGAGATACAGAGAGGGGATGTACCGAAATCAA
TCCAGTGTTACATGCATGAAACTGGTGCCTCGGAG GAAGTTGCTCGTGAGCACATCAAGGATATGATGAG
ACAGATGTGGAAGAAGGTGAATGCATACACAGCGG
ATAAAGACTCTCCCTTGACTCGAACAACTACTGAGT
TCCTCTTGAATCTTGTGAGAATGTCCCATTTTAT
GTATCTACATGGAGATGGGCATGGTGTTCAAAACCA
AGAGACTATCGATGTCGGTTTTACATTGCTTTTT
CAGCCCATTCCCTTGGAGGACAAAGACATGGCTTTC
ACAGCATCTCCTGGCACCAAAGGCTGATGATGAA
TTATAATGCACGATGCGTTGCGAATTCCCAGAGAGT
GCAGTTTCAGTTGATGTTGGCCTCCGCTTTTCTT
TCTTCTGAGGGATCTCTTTTCGATAATAAAATAAAT
TCCCTCATTCATCAAGGTTTATAAATGAAAAAGA
AATGATATATACATATATGTTACTTTTATTGAGAAT
AAAAGTCTTCAGGATATGCAAATA
R-!imonenc MSSCINPSTLVTSINGF CLPLATN AAIRIMAKNKPV synthase from QCLVSAKYDNLTVDRRSANYQPSIWDHDFLQS Citrus sinensis LNSNYTDQTYRRPvAEELKG VKTAIKDVTEPLDQLELI
DNLQRLGLAYHFETEIRNILHNIYNN KDYIW
RKANLYATSLEFRLLRQHGYPVSQEVFSGFKDDKGGF
ICDDFKGILSLHEASYYSLEGESIMEEAWQFTS
KHLKETMIISNSKEEYVFVAEQAKRALELPLHWKVPT
LEARWFIHVYEKREDKNHLLLELAKLEFNTLQA
IYQEELKDISGWWKDTGLGEKLSFARNRLVASFLWSM
GIAFEPQFAYCRRVLTISIALITVIDDIYDVYG
TLDELEIFTDAVARWDI YALKHLPGYMKMCFLALY
NFV EFAYYVLKQQDFDMLLSIKNAWLGLIQAYL
VEAKWYHSKYTPKLEEYLENGLVSITGPLIIAISYLSGT
NPIIKKELEFLESNPDIVHWSSKIFRLQDDL
GTSSDEIQRGDVPKSIQCYMHETGASEEVAREHIKDM
MRQMWKKVNAYTADKDSPLTRTTTEFLLNLVRM
SHFMYLHGDGHGVQNQETIDVGFTLLFQPIPLEDKDM
AFTASPGT G
linalool synthase ATGTGTACTATTATTAGCGTAAATCATCATCATGTG from Mentha GCGATCCTTAGCAAGCCTAAAGTAAAACTTTTCC citrata ACACCAAAAACAAGAGATCAGCTTCAATTAATCTCC
CATGGAGTCTCTCTCCTTCTTCATCCGCCGCCTC
TCGCCCCATCAGTTGTTCTATCTCCTCAAAACTATAT
ACCATCAGTTCGGCTCAGGAGGAAACCCGACGT
TCCGGAAACTACCACCCTTCAGTTTGGGATTTTGAT
TTCATTCAATCTCTCGACACTGATCACTATAAGG
AGGAGAAGCAGTTAGAGAGGGAGGAAGAGCTGATC
ATGGAGGTGAAGAAGTTGTTGGGGGCAAAAATGGA
GGCAACTAAGCAGTTGGAGTTGATTGATGACTTGCA GAATTTGGGATTGTCTTATTTTTTCCGAGACGAG
ATTAAG AATATCTTG AATTCT ATATAT AAAATTTTC C
AAAATAATAATAGTACTAAAGTAGGGGATTTGC
ATTTCACGTCTCTTGGATTCAGGCTCCTCCGGCAGC
ATGGTTTCAACGTTTCACAAGGAGTATTTGATTG
CTTCAAGAACGAGCATGGTAGCGATTTCGAGAAAA
CCCTAATTGGGGAAGATACGAAAGGAGTGCTGCAA
CTTTACGAAGCATCATTCCTTTTGAGAGAAGGTGAA
GATACATTGGAGGTAGCTAGAAAATTCTCCACCG
AATTTCTCGAGGAAAAACTCAAAGCCGGAATCGAT
GGTGATAATCTATCATCATCGATTGGCCATTCTTT
GGAGATCCCTCTTCACTGGAGGATTCAAAGACTAGA
GGAAAGATGGTTCTTAGATGCTTACTCAAGGAGG
AAAGACATGAACCCTATCATTTTCGAGCTCGCCAAA
CTCGACTTCAATATTATTCAAGCAACGCAGCAAG
AAGAACTCAAAGATCTCTCAAGGTGGTGGAATGATT
CAAGCCTACCTCAAAAACTCCCATTTGTGAGGGA
TAGGCTGGTGGAAAGCTACTATTGGGCCCTTGGGTT
GTTTGAGGCTCACAAATTTGGATATGAAAGAAAA
ACTGCTGCAAAGATTATTACCCTAATTACAGCTCTT
GATGATGTTTATGATATTTATGGCACACTCGACG
AGCTCCAACTATTTACACACGTCATTCGAAGATGGG
ATACTGAATCAGCCACCCAACTTCCTTATTACTT
GCAATTATTCTATTTCGTACTATACAACTTTGTTTCC
GAGGTGGCGTACCACATTCTAAAGGAAGAGGGT
TTCATCAGCATCCCATTTCTACACAGAGCGTGGGTG
GATTTGGTTGAAGGATATTTACAAGAGGCAAAGT
GGTACTACACTAAATATACACCAACCATGGAAGAA
TATTTGAACTATGCCAGCATCACAATAGGGGCTCC
TGCAGTAATATCCCAAATTTATTTTATGCTAGCCAA
ATCGAAAGAGAAACCGGTGATCGAGAGTTTTTAC
GAATACGACGAAATAATTCGCCTTTCGGGAATGCTC
GTGAGGCTTCCCGATGACCTAGGAACACTACCGT
TTGAGATGAAGAGAGGCGACGTGGCGAAATCAATC
CAGATTTACATGAAGGAACAGAATGCAACACGGGA
AGAAGCAGAAGAACACGTGAGGTTTATGATTAGGG
AGGCGTGGAAGGAGATGAACACAACTATGGCGGCG
AATTCTGATTTGAGAGGTGATGTGGTTATGGCTGCA
GCTAATCTTGGAAGGGATGCACAGTTTATGTATC
TCGACGGAGACGGTAACCACTCTCAGTTACAACACC
GGATTGCGAACTTGCTGTTCAAGCCATATGTCTGA
linalool synthase MCTII S V HHHVAIL SKPKVi LFHTi NKRS ASI LP WS from Mentha LSPSSSAASRPISCSISSKLYTISSAQEETRRSGNYHPSV citrata WDFDFIQSLDTDHYKEEKQLEREEELIMEV KLLGAK
MEATKQLELIDDLQNLGLSYFFRDEIKNILNSIYKIFQN
N STKVGDLHFTSLGFRLLRQHGFNVSQGVFDCFK E
HGSDFE TLIGEDTKGVLQLYEASFLLREGEDTLEVAR
KFSTEFLEEKLKAGIDGDNLSSSIGHSLEIPLHWRIQRL
EERWFLDAYSRRKDMNPIIFELAKLDFNIIQATQQEEL
KDLSRWWNDSSLPQKLPFVRDRLVESYYWALGLFEA
HKFGYERKTAAKIITLITALDDVYDIYGTLDELQLFTH
VIRRWDTESATQLPYYLQLFYFVLY FVSEVAYHILKE
EGFISIPFLHRAWVDLVEGYLQEAKWYYTKYTPTMEE
YLNYASITIGAPAVISQIYFMLAKSKEKPVIESFYEYDEI
IRLSGMLVRLPDDLGTLPFEMKRGDVAKSIQIYMKEQ
NATREEAEEHVRFMIREAWKEMNTTMAANSDLRGDV
VMAAANLGRDAQFMYLDGDGNHSQLQHRIANLLFKP
YV
γ-terpinene ATGGCTCTTAATCTGCTATCTTCACTACCTGCGGCA synthase from GGCAATTTCACCATATTATCATTACCATTATCAA Citrus unshiu GCAAAGTTAATGGCTTTGTTCCTCCTATTACTCGAGT
CCAATATCCCATGGCTGCATCCACTACTTCTAT
TAAGCCTGTCGATCAAACCATTATTAGGCGATCTGC
CGATTACGGGCCAACCATTTGGAGTTTTGATTAT
ATTCAATCACTTGACAGTAAATATAAAGGAGAATCG
TATGCCAGACAATTGGAAAAGCTGAAGGAACAAG
TAAGCGCGATGCTACAGCAGGATAATAAAGTGGTG
GATTTGGATCCTTTACATCAACTTGAGCTCATCGA
TAATCTGCACAGACTTGGAGTATCTTATCACTTTGA
GGATGAAATAAAAAGAACTTTGGATAGGATACAC
AACAAGAATACTAATGAAAATTTATATGCCACAGC
ACTCAAATTTAGAATCCTAAGGCAATATGGTTACA
ATACACCTGTAAAAGAAACTTTTTCACATTTCATGG
ATGAGAAGGGGAGCTTTAAGTCATCAAGCCACAG
TGACGACTGCAAAGGAATGTTAGCTCTGTATGAAGC
TGCATACCTCCTGGTAGAAGAAGAAAGCAGTATC
TTTCGTGACGCTATAAGGTTCACCACCGCATATCTC
AAAGAATGGGTGGTCAAGCATGATATTGACAAAA
ATGATGATGAATATCTTTGTACATTAGTTAAACATG
CTTTGGAACTTCCATTACATTGGAGGATGCGAAG
ATTGGAGGCAAGGTGGTTCATCGATGTATACGAAA
GTGGACCAGACATGAACCCTATCTTGCTCGAGCTC
GCTAAACTTGACTATAATATTGTGCAAGCAATACAC
CAAGAGGATCTCAAATATGTGTCAAGGTGGTGGA
TGAAAACAGGACTTGGGGAGAAGTTGAATTTTGCA
AGAGACAGAGTAGTGGAGAATTTCTTCTGGACCGT GGGAGATATATTCGAACCTCAGTTTGGATATTGTAG
AAGGATGTCTGCAATGGTTAATTGTCTTTTAACA
TCAATCGATGATGTTTATGATGTCTATGGGACCTTG
GACGAACTTGAGCTATTCACTGATGCAGTTGAGA
GATGGGACGCTACTGCAACAGAGCAACTTCCGTACT
ATATGAAGCTGTGCTTTCATGCTCTCTATAATTC
CGTAAATGAAATGGGTTTTATTGCTCTCAGAGATCA
AGAAGTTGGCATGATCATTCCTTATCTTAAGAAA
GCGTGGGCAGATCAATGCAAATCATATTTAGTGGAG
GCAAAGTGGTACAACAGCGGCTACATACCAACTC
TTCAAGAATATATGGAAAACGCTTGGATTTCAGTAA
CAGCACCTGTAATGCTACTCCATGCGTATGCTTT
TACAGCAAATCCAATAACAAAGGAGGCCTTGGAAT
TCTTGCAGGATTCTCCCGATATAATTCGTATTTCA
TCAATGATTGTACGACTTGAAGACGATTTGGGAACA
TCATCGGATGAGCTGAAGAGGGGAGATGTTCCCA
AATCAATTCAATGTTACATGCATGAAACTGGAGTTT
C AGAGGATGAGGCTC GTGAAC AT ATAC GAGATTT
GATTGCTGAGACATGGATGAAGATGAACAGTGCTC
GATTCGGAAACCCACCTTACTTGCCCGATGTTTTC
ATTGGGATTGCAATGAATTTGGTGAGGATGTCTCAA
TGCATGTACCTATATGGAGATGGACACGGTGTAC
AAGAA AATAC C AAGG ATC GTGT ATTGTCTTT ATTT A
TTGATCCCATTCCTTAA
γ-terpinene MALNLLSSLPAAGNFTILSLPLSSKVNGFVPPITRVQYP synthase from MAASTTSIKPVDQTIIRRSADYGPTIWSFDY
Citrus unshiu IQSLDS YKGESYARQLEKLKEQVSAMLQQDNKVVD
LDPLHQLELIDNLHRLGVSYHFEDEIKRTLDRIH
NKNTNENLYATALKFMLRQYGYNTPVKETFSHFMDE
KGSFKSSSHSDDCKGMLALYEAAYLLVEEESSI
FRDAIRFTTAYLKEWVVKHDIDK DDEYLCTLVKHAL
ELPLHWRMRRLEARWFIDVYESGPDMNPILLEL
AKLDYNIVQAIHQEDLKYVSRWWMKTGLGEKLNFAR
DRVVENFFWTVGDIFEPQFGYCRRMSAMVNCLLT
SIDDVYDVYGTLDELELFTDAVERWDATATEQLPYY
MKLCFHALYNSVNEMGFIALRDQEVGMIIPYLKK
AWADQCKSYLVEAKWYNSGYIPTLQEYMENAWISVT
AP VMLLHAYAFTANPIT EALEFLQD SPDIIRI S
SMIVRLEDDLGTSSDELKRGDVPKSIQCYMHETGVSE
DEAREHIRDLIAETWMKMNSARFGNPPYLPDVF
IGIAMNLVRMSQCMYLYGDGHGVQENTKDRVLSLFID
PIP
γ-terpinene ATGGCCTCACTGCAAGTCGAGGAAGAAACCCGGCG synthase from Thymus caespititius TTCTGGGAACTACCAGGCTTCCATTTGGGACAATG CTTTCATTCAATCTTTCAATACAAATAAATATAGGG ACGAGAAGCACTTGAACAGGAAAGAAGAGCTGAT TGCACAAGTGAAGGTACTGTTGAACACAAAAATGG AGGCTGTTAAGCAATTGGAGTTGATTGATGACTTG AGAAATCTAGGGTTGACTTATTATTTTCAAGATGAG TTTAAGAAGATTCTTACTTGTATATATAATGATC ACAAATGTTTCAAAAACGAACAAGTTGGGGATTTGT ACTTCACATCTCTTGGATTCAGACTCCTCAGACT ACACGGTTTCGATGTCTCAGAAGAAGTGTTTAGCTT TTTTAAGAACGAGGATGGTAGTGATTTCAAGGCG AGCCTTGGTGAAAATACGAAGGACGTATTGCAACTT TACGAGGCATCGTTCCTTGTAAGGGTAGGTGAAG TTACACTGGAGCAAGCAAGGGTATTTTCCACTAAAA TTCTGGAAAAGAAAGTCGATGAGGGAATTAATGA TGAAAAATTATTAGCATGGATTCAACATTCTTTGGC TCTCCCTCTTCACTGGAGGATTCAAAGGCTAGAG GCGAGATGGTTCTTAGATGCTTACGCGGCGAGGAA GGACATGAATCCTCTTATCTTCGAGCTCGGGAAAA TAGACTTCCATATTATTCAAGAAACACAACTAGAAG AAGTCCAAGAGGTTTCGAGGTGGTGGACTAATTC TAACCTCGCCGAGAAACTGCCATTTGTGAGAGATAG AATTGTGGAGTGCTACTTTTGGGCGCTTGGGCTC TTTGAGCCACATGAATATGGATACCAGAGAAAAAT GGCCGCAATTATCATCACTTTCGTTACAATCATAG ACGATGTTTACGACGTCTATGGAACACTCGACGAAC TGCAGCTATTCACGGACGCGATTCGAAAATGGGA CTTTGAATCAATAAGCACACTTCCATATTACATGCA AGTTTGCTATTTGGCACTCTACACCTATGCTTCT GAGCTGGCTTATGATATTCTCAAAGATCAGGGTTTC AACAGCATCTCATACCTACAGAGATCGTGGCTGA GTTTGGTCGAAGGGTTTTTCCAAGAGGCAAAATGGT ACTACGCTGGATACACGCCGACCCTAGCAGAATA CCTAGAGAACGCCAAAGTTTCAATATCGTCTCCAAC TATTATATCTCAAGTTTACTTCACTCTCCCGAAT TCGACTGAGAGAACGGTTGTCGAGAACGTCTACGG ATACCACAACATACTCTATCTTTCCGGCATGATTT TAAGGCTTGCTGATGATCTTGGTACAACTCAGTTTG AGCTGAAGAGAGGGGACGTGCAAAAGGCGATCCA GTGCTACATGAAGGACAACAATGCCACAGAGAAAG AAGGGCAAGAGCACGTGAAGTATCTGTTGCTAGAG GCGTGGAAGGAGATGAACACGGCGATGGCGGACCC CGACTGCCCGTTGTCTGAGGATCTGGTGGATGCAG CAGCTAATCTGGGAAGAGCATCTCAGTTCATATATC TCGAAGGAGATGGCCATGGCGTGCAGCACTCGGA GATTCATAACCAGATGGGAGGCCTTATTTTCGAGCC ATATGTGTGA
γ-terpinene MASLQVEEETRRSGNYQASIWDNAFIQSFNTNKYRDE synthase from KHLNRKEELIAQVKVLLNTKMEAVKQLELIDDL Thymus caespititius R LGLTYYFQDEFKKILTCIYNDH CFK EQVGDLYF
TSLGFRLLRLHGFDVSEEVFSFFKNEDGSDFKA
SLGENTKDVLQLYEASFLVRVGEVTLEQARVFSTKILE
KKVDEGINDEKLLAWIQHSLALPLHWRIQRLE
ARWFLDAYAARKDMNPLIFELGKIDFHIIQETQLEEVQ
EVSRWWTNSNLAEKLPFVRDRIVECYFWALGL
FEPHEYGYQRKMAAIIITFVTIIDDVYDVYGTLDELQLF
TDAIR WDFESISTLPYYMQVCYLALYTYAS
ELAYDILKDQGFNSISYLQRSWLSLVEGFFQEAKWYY
AGYTPTLAEYLENAKVSISSPTIISQVYFTLPN
STERTVVENVYGYHNILYLSGMILRLADDLGTTQFEL
KRGDVQKAIQCYMKO NATEKEGQEHVKYLLLE
AWKEMNTAMADPDCPLSEDLVDAAANLGRASQFIYL
EGDGHGVQHSEIHNQMGGLIFEPYV
γ-terpinene ATGGCTACCCTTAGCATGCAAGTGTCCATACTTAGC synthase from AAGGAAGTGAAAAATGTCAACAACATTGGCATGA Origanum vulgare GAGCATCTAAACCAATGGTGGCGAGGCGCGTCTCTA
CCACTCGTCTCCGGCCTATTTGCTCCGCCTCACT
GCAAGTCGAAGAAGAAACCCGACGTTCCGGAAACT
ACCAGGCTTCAATTTGGAACAATGATTACGTTCAA
TCTTTCAACACAAATCAATATAAGGACGAGAAGCA
CTTGAAAAAGAAAGAAGAGCTGATTGCACAAGTAA
AGATATTGTTGAACACAAAAATGGAGGCTGTTAAA
CAATTGGAGTTGATTGAAGACTTGAGAAATCTAGG
GTTGACTTATTATTTTCAAGATGAGGTTAAGAAGAT
TCTTACTTCTATATATAATGATCACAAATGTTTC
AAAAACGAACAAGTTGGGGATTTGTATTTTACTTCT
CTTGGATTCAGACTCCTCAGACTGCACGGTTTCG
ATGTCTCAGAAGAGGTGTTTGACTTTTTTAAGAACG
AGGATGGTAGTGATTTCAAGGCGAGCCTTGGTGA
AAATATAAAAGACGTATTGCAGCTTTACGAAGCATC
TTTCCTTATAAGGGAAGGTGAAGTTATACTGGAG
CAAGCAAGAGTATTTTCCACCAAACATCTTGAAAAG
AAAGTTGATGAGGGAATTAATGATGAAAAATTAT
TAGCATGGATTCGCCATTCTTTGGCTCTCCCTCTTCA
TTGGAGGATTCAAAGGCTAGAGGCGAGGTGGTT
CTTAGATGCTTACAGGGCGAGGAAAGACATGATTCC TCTTATTTTCGAGCTCGGGAAAATCGACTTCCAT
ATCATTCAAGAAACACAACTAGAAGAACTCCAAGA
AGTCTCAAAGTGGTGGACTAATTCAAACCTCGCCG
AGAAACTCCCATTTGTGAGAGATAGAATTGTGGAGT
GCTACTTTTGGGCGCTTGGGCTCTTTGAACCACA
TGAGTATGGTTATCAGAGGAAAATGGCTGCCATTAT
TATCACTTTCGTTACGATCATAGACGATGTTTAC
GACGTCTACGGTACACTCGACGAACTGCAGCTATTC
ACCGACGCGATTCGAAAATGGGACTTTCAATCAA
TAAGCACACTTCCATACTACATGCAAGTTTGCTATT
TGGCACTCTACACCTATGCTTCTGAACTGGCTTA
TGATATTCTCAAAGATCAAGGTTTCAACAGTATTGC
TTATCTACAAAGATCGTGGCTGAGTTTGGTGGAA
GGATTTTTCCAAGAGGCAAAATGGTACTACGCCGGG
TACACGCCAACCCTAGCAGAATACCTAGAGAACG
CCAAAGTTTCAATATCATCTCCTACTATTATCTCTCA
AGTTTACTTCACTCTTCCGAATTCGACTGAGAG
AACGGTTGTCGAAAACGTCTTCGGATACCACAACAT
ACTCTACCTTTCCGGAATGATTTTAAGGCTTGCA
GATGATCTTGGCACTACTCAGTTTGAGCTGAAGAGA
GGGGACGTGCAAAAGGCAATCCAGTGTTACATGA
AGGACAACAATGCTACAGAGAAAGAAGGGGCTGAG
CATGTGAAGTATCTGTTACGAGAAGCGTGGAAGGA
GATGAACACGGCGATGGCGGACCCCGAGTGCCCGT
TGTCGGAAGATCTGGTGGATGCTGCTGCTAATCTG
GGGAGAGCATCTCAGTTCATATATCTGGAAGGAGAT
GGCCACGGCGTTCAGCACTCAGAGATTCATAACC
AAATGGGAGGCCTTATTTTCGAGCCATATGTGTGA
γ-terpinene MATLSMQVSILSKEVKNV NIGMRASKPMVARRVST synthase from TRLRPIC SASLQVEEETRRSGNYQASIW DYVQ Origanum vulgare SFNTNQYKDEKHLKKKEELIAQVKILLNTKMEAVKQL
ELIEDLR LGLTYYFQDEVKKILTSIY DHKCF
K EQVGDLYFTSLGFRLLRLHGFDVSEEVFDFFK ED
GSDFKASLGENIKDVLQLYEASFLIREGEVILE
QARVFSTKHLEKKVDEGINDEKLLAWIRHSLALPLHW
RIQRLEARWFLDAYRARKDMIPLIFELGKIDFH
IIQETQLEELQEVSKWWTNSNLAEKLPFVRDRIVECYF
WALGLFEPHEYGYQRKMAAIIITFVTIIDDVY
DVYGTLDELQLFTDAIRKWDFQSISTLPYYMQVCYLA
LYTYASELAYDILKDQGFNSIAYLQRSWLSLVE
GFFQEA WYYAGYTPTLAE YLEN A V SI S SPTIIS Q V Y
FTLPNSTERTVVENVFGYHNILYLSGMILRLA
DDLGTTQFELKRGDVQKAIQCYMKD ATEKEGAEH VKYLLREAWKEMNTAMADPECPLSEDLVDAAANL GRASQFIYLEGDGHGVQHSEIHNQMGGLIFEPYV
Ε-β-ocimene ATGGCCCAGAGCTTTTCCATGGTGCTCAATTCGTCC synthase from TTCACTTCACATCCTATTTTTTGCAAACCTCAAA Lotus japonicas AGCTAATTATAAGAGGGCATAATCTACTTCAAGGGC
ACAGAATTAATTCCCCAATTCCATGCTATGCAAG
CACTAGCAGCACAAGTGTGTCACAAAGAAAATCAG
CCAATTACCAACCTAACATTTGGAATTACGATTAT
TTGCAGTCCTTAAAGCTTGGTTATGCGGATGCACAT
TATGAGGATATGGCTAAAAAGTTGCAAGAGGAAG
TGAGAAGAATAATTAAGGATGACAAAGCAGAGATT
TGGACTACACTAGAGCTTATTGATGATGTGAAACG
CTTGGGTCTTGGCTATCACTTTGAAAAGGAGATAAG
AGAGGTTCTTAACAAGTTTCTATCTTTGAACACA
TGTGTTCATAGAAGCTTGGATAAGACTGCTCTATGC
TTTAGGCTCTTGAGAGAATACGGCTCCGATGTAT
CAGCAGATATTTTTGAGAGATTCTTGGACCAAAATG
GTAATTTCAAGACAAGTCTTGTCAATAATGTAAA
AGGAATGTTGAGTCTCTATGAGGCATCATTTCTTTCT
TATGAAGGAGAACAGATTTTGGATAAGGCCAAT
GCTTTCACTAGCTTTCATCTCAAGAGCATCCATGAA
GAAGATATAAATAACATTCTCTTAGAACAAGTGA
ATCATGCATTGGAGCTTCCACTACATCGTCGTATCC
ACAGGCTTGAGGCCCGGTGGTACACTGAGTCATA
TTCAAGAAGAAAGGATGCAAATTGGGTGTTGCTTGA
AGCAGCTAAACTGGATTTCAACATGGTTCAATCA
ACACTGCAAAAAGATCTCCAAGAAATGTCAAGGTG
GTGGAAGGGGATGGGGCTTGCCCCAAAGTTAAGCT
TCAGTCGTGATAGATTAATGGAGTGCTTCTTTTGGA
CGGTTGGGATGGCTTTTGAGCCAAAATACAGTGA
TCTTCGCAAAGGTTTAACCAAAGTCACCTCTTTAAT
AACTACAATTGATGACATTTATGATGTGCATGGA
ACCTTGGAAGAATTAGAGCTTTTCACAGCAATTGTG
GAAAGTTGGGACATTAAAGCAATGCAAGTTCTCC
CAGAATACATGAAGATAAGCTTCTTAGCCCTCTACA
ACACAGTCAATGAATTGGCTTATGATGCACTTAG
AGAACAAGGGCATGATATCCTACCCTACCTCACTAA
AGCATGGTCTGATATGTTGAAAGCTTTCCTACAA
GAAGCAAAGTGGTGCCGAGAAAAACACTTGCCAAA
ATTTGAGCATTATCTCAATAATGCTTGGGTCTCAG
TGTCTGGTGTAGTTATACTAACTCATGCCTATTTCTT
GCTGAATCACAACACAACAAAGGAGGTACTTGA
GGCCTTGGAAAATTACCATGCTCTGTTAAAAAGACC ATCCATAATTTTTCGACTTTGCAATGATTTGGGT
ACATCAACGGCGGAGTTACAGAGAGGTGAAGTAGC
AAATTCAATTTTATCCTGCATGCATGAAAATGATA
TTGGTGAAGAGAGTGCTCACCAACACATTCATAGTT
TGCTTAATGAAACTTGGAAGAAGATGAATAGAGA
TAGGTTCATCCACTCACCTTTCCCAGAACCTTTTGTG
GAAATAGCAACCAACCTAGCCAGAATTGCTCAG
TGTACGTACCAAACTGGAGATGGGCATGGAGCCCC
GGATAGTATAGCAAAGAATCGAGTCAAATCATTGA
TAATTGAACCCATTGTTCTCAATGGAGACATATATT
AA
Ε-β-ocimene MAQSFSMVLNSSFTSHPIFCKPQKLII GHNLLQGHRIN synthase from SPIPCYASTSSTSVSQRKSANYQPNIW YDY
Lotus japonicas LQSLKLGYADAHYEDMAKKLQEEVRRIIKDDKAEIWT
TLELIDDVKRLGLGYHFEKEIREVLNKFLSLNT
CVHRSLD TALCFRLLREYGSDVSADIFERFLDQNGNF
KTSLV VKGMLSLYEASFLSYEGEQILDKAN
AFTSFHLKSIHEEDI NILLEQVNHALELPLHRRIHRLE
ARWYTESYSRRi DANWVLLEAAKLDFNMVQS
TLQKDLQEMSRWWKGMGLAPKLSFSRDRLMECFFW
TVGMAFEPKYSDLRKGLTKVTSLITTIDDIYDVHG
TLEELELFTAIVESWDIKAMQVLPEYMKISFLALYNTV
NELAYDALREQGHDILPYLTi AWSDMLKAFLQ
EAKWCREKHLPKFEHYLN AWVSVSGVVILTHAYFL
LNHNTTKEVLEALE YHALLKRPSIIFRLCNDLG
TSTAELQRGEVANSILSCMHENDIGEESAHQHIHSLLN
ETWKKMNRDRFIHSPFPEPFVEIATNLARIAQ
CTYQTGDGHGAPDSIAK RVKSLIIEPIVLNGDIY
Ε-β-ocimene ATGCCTAAACGACAGGCTCAACGGCGTTTCACTCGC synthase from AAGACTGACTCGAAAACACCATCCCAGCCTCTGG Arabidopsis TATCCCGTCGCTCTGCAAACTATCAACCGTCTCTTTG thaliana GCAGCACGAATATCTCCTCTCGCTCGGTAATAC
ATATGTGAAAGAGGACAACGTCGAGAGAGTTACGT
TATTGAAGCAGGAAGTGAGTAAAATGCTCAATGAA
ACGG AAGGTTTACTC GAAC AGCTAG AGCTC ATC GAC
ACTTTACAAAGGCTTGGAGTTTCTTACCATTTTG
AACAAGAAATCAAGAAGACACTAACGAATGTGCAT
GTTAAAAATGTGCGAGCACACAAAAACCGGATAGA
TCGAAACCGATGGGGAGATTTATACGCGACCGCCCT
TGAGTTCCGACTCCTAAGGCAACATGGTTTCAGT
ATCGCACAAGATGTTTTTGACGGAAATATTGGAGTT
GATTTGGATGATAAAGACATCAAGGGTATTCTTT
CACTATACGAAGCTTCATATCTCTCGACCAGAATCG ATACTAAATTGAAAGAGAGCATATACTATACAAC
AAAACGACTTAGAAAATTTGTGGAGGTAAATAAGA
ATGAGACCAAATCTTACACTCTTCGAAGGATGGTT
ATACATGCGTTAGAGATGCCGTACCACCGGAGAGT
GGGAAGACTAGAAGCAAGATGGTACATAGAAGTGT
ACGGAGAGAGACACGACATGAACCCTATCTTGCTTG
AACTCGCGAAACTTGATTTTAATTTCGTACAAGC
TATCCATCAAGACGAGCTCAAATCCCTCTCTAGTTG
GTGGAGCAAGACGGGATTAACAAAACACCTCGAT
TTCGTTAGAGATCGAATAACGGAGGGTTATTTCTCG
AGTGTTGGAGTAATGTATGAGCCCGAGTTTGCAT
ATCACCGACAAATGCTTACAAAGGTTTTCATGCTCA
TTACAACTATCGACGATATATACGATATTTATGG
GACACTTGAGGAGCTCCAACTATTCACGACCATAGT
TGAAAAATGGGATGTGAATCGTCTTGAAGAACTT
CCCAACTACATGAAGTTATGTTTTCTCTGCCTCGTCA
ACGAAATCAATCAGATTGGATATTTTGTACTCA
GAGATAAAGGGTTTAATGTGATTCCTTACCTCAAAG
AATCTTGGGCAGATATGTGTACAACGTTTTTGAA
AGAGGCAAAGTGGTATAAAAGTGGTTACAAACCTA
ACTTCGAAGAATACATGCAAAATGGTTGGATCTCA
AGCTCAGTCCCTACAATACTTCTACACTTGTTCTGTC
TCTTATCCGACCAAACCTTAGACATTCTTGGCT
CCTACAATCACTCTGTAGTTCGAAGCTCCGCCACCA
TCCTCCGTCTCGCTAACGATCTCGCCACTTCTTC
GGAGGAATTAGCGAGAGGCGACACTATGAAATCCG
TACAATGTCACATGCATGAAACTGGAGCTTCGGAG
GCAGAGTCACGCGCGTACATTCAAGGAATTATCGGT
GTGGCTTGGGATGACTTAAACATGGAGAAAAAGA
GTTGTAGGCTACATCAAGGTTTCCTAGAAGCTGCGG
CTAATCTTGGACGTGTGGCTCAGTGCGTTTATCA
GTACGGTGATGGCCATGGCTGTCCTGACAAGGCTAA
GACCGTCAATCATGTCCGGTCCTTGCTCGTCCAC
CCTCTTCCACTCAATTAA
Ε-β-ocimene MPKRQAQRRFTRKTDSKTPSQPLVSRRSANYQPSLWQ synthase from HEYLLSLGNTYVKEDNVE VTLLKQEVSKMLNE
Arabidopsis TEGLLEQLELIDTLQRLGVSYHFEQEIKKTLTNVHVKN thaliana VRAHKNRIDRNRWGDLYATALEFRLLRQHGFS
IAQDVFDGNIGVDLDDKDI GILSLYEASYLSTRIDTKL
KESIYYTTKRLRKFVEVNKNETKSYTLRRMV
IHALEMPYHRRVGRLEARWYIEVYGERHDMNPILLEL
AKLDFNFVQ AIHQDELKSLS S WWSKTGLTKHLD
F VRDRITEGYF S S VGVMYEPEF AYHRQMLTKVFMLIT TIDDIYDIYGTLEELQLFTTIVEKWDV RLEEL
PNYMKLCFLCLV EINQIGYFVLRDKGFNVIPYLKESW
ADMCTTFLKEA WYKSGYKPNFEEYMQNGWIS
SSVPTILLHLFCLLSDQTLDILGSYNHSWRSSATILRLA
NDLATSSEELARGDTM SVQCHMHETGASE
AESRAYIQGIIGVAWDDLNMEK SCRLHQGFLEAAAN
LGRVAQCVYQYGDGHGCPDKA TV HVRSLLVH
PLPLN
Figure legends
Figure 1 The Mevalonate pathway
Figure 2 The MEP pathway
Figure 3 Plasmid map of integration vector
Figure 4 Plasmid map of broad host self-replicating plasmid
Figure 5 GC-results: Counts vs acquisition time. Part where limonene elutes (around 6.75 minutes) is zoomed
Figure 6 GC-results: FID units pA vs acquisition time. Part where linalool elutes (around 7.2 minutes) is zoomed
Figure 7 Linalool production from a batch culture
Examples
The present invention is further described by the following examples which should not be construed as limiting the scope of the invention.
Unless stated otherwise, the practice of the invention will employ standard conventional methods of molecular biology, virology, microbiology or biochemistry.
Such techniques are described in Sambrook et al. (1989) Molecular Cloning, A Laboratory Manual (2nd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press; in Sambrook and Russell (2001) Molecular Cloning: A Laboratory Manual, Third Edition, Cold Spring Harbor Laboratory Press, NY; in Volumes 1 and 2 of Ausubel et al. (1994) Current Protocols in Molecular Biology, Current Protocols, USA; and in Volumes I and II of Brown (1998) Molecular Biology LabFax, Second Edition, Academic Press (UK); Oligonucleotide Synthesis (N. Gait editor); NucleicAcid Hybridization (Hames and Higgins, eds.). Example 1. Enzymes for production of the monoterpene limonene.
The inventors have introduced a specific two-enzyme pathway into a cyanobacterial cell to produce limonene.
Limonene is a simple cyclic CIO terpene with no rare groups. Limonene is chiral and exists in two enantiomeric forms R-limonene and S-limonene. In nature R-limonene is the most abundant and is commercially harvested from citrus rinds. The other enantiomer S-limonene enantiomer is also found in nature and is the precursor for menthol.
Limonene like other monoterpenes is made in two steps from the isoprenoid precursors. In the first step IPP and DMAPP are condensed by Geranyl diphosphate synthase (GPPS) to form geranyl diphosphate (GPP). In the second step, the enzyme Limonene Synthase (LS) catalyzes the cyclization of GPP to limonene. To make limonene in Synechocystis, we chose the following two GPP synthases (1) The gene gpps from Abies grandis (SEQ ID NO: 1, 2) and (2) 197A mutant of erg20 gene, the FPP synthase from Saccharomyces cerevisiae (SEQ ID NO: 3, 4). We chose the limonene synthase (LS) from Mentha spicata which is specific for S-limonene (SEQ ID NO: 5, 6). The LS from Mentha spicata and the GPPS from Abies grandis were also truncated to remove the N-terminal plastidic targeting signals. Example 2. Biochemical Background of a cyanobacterial cell according to the present invention
The genes encoding the LS from Mentha spicata and the GPPS from Abies grandis were co don-optimized for expression in Synechocystis and obtained through chemical synthesis. While the erg20 gene was amplified from Saccharomyces cerevisiae and the mutation Kl 97A was introduced by overlap-extention PCR. These genes were each cloned with a trc promoter into an integration vector, containing sequences to facilitate (double) homologous recombination with the neutral site slrO 168 in the cyanobacterial genome, and a kanamycin marker, which confers resistance to kanamycin. The genes were introduced either as operons, with both genes sharing the same trc promoter or as independent transcription cassettes, with a trc promoter for each gene. This led to making of 4 plasmids,
1. LS from Mentha spicata and the GPPS from Abies grandis as operon (LG-op)
2. LS from Mentha spicata and the GPPS from Abies grandis as cassette (GL-cas)
3. LS from Mentha spicata and the ERG20 mutant from Saccharomyces cerevisiae as operon (EL-op) 4. LS from Mentha spicata and the ERG20 mutant from Saccharomyces cerevisiae as cassette (EL-cas)
Each plasmid was transformed into Synechocystis PCC 6803 as described in patent application EP2563927.
Example 3. Production of limonene by a cyanobacterial cell
Mutant cultures were grown to an OD730 = 1 to 3 and were used for limonene measurements. 2mL or 4mL of a select culture was transferred to a 20 mL glass vial and sealed. 10 to 20 mM of bicarbonate was also added to each vial and the vial incubated in low light intensity (~40 μΕ), 30° C, and shaking at 120 rpm light overnight. Next day, the vial was loaded onto an automated GCMS (Agilent Technologies 7200 Accurate-Mass Q-TOF GCMS). In the first step, the vial was heated for 10 min at 55 deg C, to release all volatiles into the headspace. Then a needle carrying a SPE (solid phase extraction) cartridge was inserted into the vial and incubated for 10 minutes, to allow all volatiles to bind. The needle was them injected into the GC and volatiles loaded onto the column and separated and determined by MS. Similar experiments were done with a known amount of Limonene to obtain a standard curve as well as with a wild- type culture as negative control. Limonene elutes at a retention time of around 6.75 minutes. All four strains obtained in example 2: LG- op, GL-cas, EL-op, and EL-cas, were tested. Figure 5 shows the counts vs acquisition time plots obtained from GC analysis. From the figure, it is evident that LG-op, GL-cas, EL-op, and EL-cas all produce limonene while the wild-type strain did not produce any limonene. In addition, the results show that best combination of enzymes is the LS from Mentha spicata and the GPPS from Abies grandis. Moreover, yields are higher when the genes are inserted into Synechocystis as individual transcription cassettes wherein each gene is operably linked to its native promoter.
Example 4. Enzymes for production of the monoterpene linalool
The inventors have introduced a specific two-enzyme pathway into a cyanobacterial cell to produce linalool.
Linalool is a non cyclic CIO terpene with a hydroxyl-group. It is chiral and exists in two enantiomeric forms (R)-(-)-linalool also known as licareol and (S)-(+)-linalool also known as coriandrol. (S)-(+)-Linalool is perceived as sweet, floral, petit grain- like and the (R)-form as more woody and lavender-like. In nature R-linalool found in lavender oil while the other enantiomer S-linalool is found in coriander oil.
Linalool like limonene and other monoterpenes is made in two steps from the isoprenoid precursors. In the first step IPP and DMAPP are condensed by Geranyl diphosphate synthase (GPPS) to form geranyl diphosphate (GPP). In the second step, the enzyme Linalool Synthase (LS) catalyzes the isomerization/hydrolysis of GPP to linalool. To make linalool in Synechocystis, we chose the following GPP synthase : The gene gpps from Abies grandis (SEQ ID NO: 1, 2). We chose the linalool synthase (LinS) from Mentha citrata which is specific for R-linalool (SEQ ID NO: 17, 18). The LinS from Mentha citrata and the GPPS from Abies grandis were also truncated to remove the N-terminal plastidic targeting signals.
Example 5. Enzymes for production of γ-terpinene
Together with the GPPS (SEQ ID NO: 1, 2) mentioned above, γ-terpinene can be made using the the γ-terpinene synthase from Citrus unshiu (SEQ ID NO: 19, 20); Thymus caespititius (SEQ ID NO: 21, 22), Origanum vulgare (SEQ ID NO: 23, 24).
Example 6. Enzymes for production of Ε-β-ocimene synthase
Together with the GPPS (SEQ ID NO: 1, 2) mentioned above, Ε-β-ocimene can be made using the the Ε-β-ocimene synthase from Lotus japonicus (SEQ ID NO: 25, 26) and Arabidopsis thaliana (SEQ ID NO: 27, 28).
Example 6. Biochemical Background of a cyanobacterial cell producing linalool according to the present invention
The genes encoding the Linalool synthase (LinS) from Mentha citrata and the GPPS from Abies grandis as described in Example 4 were co don-optimized for expression in Synechocystis and obtained through chemical synthesis. These genes were each cloned with a trc promoter into an integration vector (Figure 3), containing sequences to facilitate (double) homologous recombination with the neutral site slr0168 in the cyanobacterial genome, and a kanamycin marker, which confers resistance to kanamycin. The genes were introduced as independent transcription cassettes, with a trc promoter for each gene. The genes were also cloned into a RSFlOlO-based conjugative plasmid pVZ (Figure 4) as independent transcription cassettes. This led to the provision of two plasmids,
1. Integration plasmid with Linalool synthase (LinS) from Mentha citrata and the GPPS from Abies grandis (integrated) 2. Conjugative plasmid pVZ with Linalool synthase (LinS) from Mentha citrata and the GPPS from Abies grandis (plasmid)
Each plasmid was transformed into Synechocystis PCC 6803 as described in patent application EP2563927.
Example 7. Production of linalool by a cyanobacterial cell
Mutant cultures were grown from an OD730 = 0.5 to about OD730 = 10, a 1L photobioreactors. The photobioreactors were bubbled with air/carbon-dioxide mixture and linalool formed was trapped on Supelpak SV reisn. The bound terpene was eluted with hexane and the eluate was analyzed by GC FID. Standard solution of linalool in hexane were used to obtain a calibration curve for quantitative determination. A wild- type culture was used a negative control. Linalool elutes at a retention time of around 7.2 minutes. Both strains obtained in example 2: integrated and plasmid were tested. Figure 6 shows the FID units vs acquisition time plots obtained from GC analysis. From the figure, it is evident that both strains tested produce linalool while the wild-type strain did not produce any linalool. Figure 7 shows that linalool can be produced in continuously growing cultures and maximum production rates of about 120 μg/gDW/L/day were achieved.
Reference list
1. Computational Molecular Biology, Lesk, A. M., ed., Oxford University Press, New York, 1988.
2. Biocomputing: Informatics and Genome Projects, Smith, D. W., ed., Academic Press, New York, 1993.
3. Computer Analysis of Sequence Data, Part I, Griffin, A. M., and Griffin, H. G., eds., Humana Press, New Jersey, 1994.
4. Sequence Analysis in Molecular Biology, von Heine, G., Academic Press, 1987.
5. Sequence Analysis Primer, Gribskov, M. and Devereux, J., eds., M Stockton Press, New York, 1991.
6. Carillo, H., and Lipman, D., SIAM J. Applied Math., 48: 1073, 1988.
7. Devereux, J., et al., Nucleic Acids Research 12 (1): 387, 1984.
8. Altschul, S. F. et al., J. Mol. Biol. 215:403-410, 1990. 9. BLAST Manual, Altschul, S., et al., NCBI NLM NIH Bethesda, MD 20894; Altschul, S., et al, J. Mol. Biol. 215:403-410, 1990.
10. Needleman and Wunsch, J. Mol. Biol. 48:443-453, 1970.
11. Hentikoff and Hentikoff, Proc. Natl. Acad. Sci. USA. 89:10915-10919, 1992.
12. Puigbo, E. Guzman, A. Romeu, and S. Garcia- Vallve. Nucleic Acids Res. 2007 July; 35 (Web Server issue): W126-W131.
13. Sambrook and Russel (2001) "Molecular Cloning: A Laboratory Manual (3rd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press.
14. Ausubel et al, eds., "Current protocols in molecular biology", Green Publishing and Wiley Interscience, New York, 1987.
15. Cheah et al, (2013) Biotechnol Prog 2013, 29:23-30.
16. Shestakov S V et al, (2002), Photosynthesis Research, 73: 279-284
17. Nakamura Y et al, (1999), Nucleic Acids Res. 27:66-68
18. Sambrook et al. (1989) Molecular Cloning, A Laboratory Manual (2nd edition), Cold Spring Harbor Laboratory, Cold Spring Harbor Laboratory Press
19. Volumes 1 and 2 of Ausubel et al. (1994) Current Protocols in Molecular Biology, Current Protocols, USA.
20. Volumes I and II of Brown (1998) Molecular Biology LabFax, Second Edition, Academic Press (UK).
21. Brosius et al, J Biol Chem 1985
22. Huang H-H, Camsund D, Lindblad P, Heidorn T: Design and characterization of molecular tools for a Synthetic Biology approach towards developing cyanobacterial biotechnology. Nucleic Acids Res 2010, 38:2577-2593.

Claims

Claims
1. A cyanobacterial cell capable of expressing, preferably expressing, at least one functional enzyme selected from the group of enzymes consisting of a geranyl diphosphate synthase (GPPS) and a monoterpenes synthase (MTS), said at least one functional enzyme preferably having ability to condense IPP and DMAPP to GPP.
2. A cyanobacterial cell according to claim 1, wherein the at least one functional enzyme is a heterologous enzyme.
3. A cyanobacterial cell according to claim 1 or 2,
wherein the at least one functional enzyme is selected from the group consisting of GPPS from Abies grandis, Picea abies, Arabidopsis thaliana, and Saccharomyces cerevisiae; and/or wherein the at least one functional enzyme is selected from the group consisting of monoterpene synthases from Mentha spicata, Mentha Canadensis, Abies grandis, Citrus sinensis, Mentha citrata, Citrus unshiu, Thymus caespititius, Origanum vulgare and Lotus japonicas.
4. A cyanobacterial cell according to any of the preceding claims, wherein the at least one functional enzyme comprises or consists of a polypeptide that has an amino acid sequence with at least 30% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 2, SEQ ID NO: 4, SEQ ID NO: 6, SEQ ID NO: 8, SEQ ID NO: 10, SEQ ID NO: 12, SEQ ID NO: 14, SEQ ID NO: 16, SEQ ID NO: 18, SEQ ID NO: 20, SEQ ID NO: 22, SEQ ID NO: 24, SEQ ID NO: 26 and SEQ ID NO: 28.
5. A cyanobacterial cell according to any of the preceding claims, wherein the at least one functional enzyme is encoded by a codon optimized polynucleotide.
6. A cyanobacterial cell according to any of the preceding claims, wherein the at least one functional enzyme is encoded by a polynucleotide that has an nucleic acid sequence with at least 30% sequence identity with a sequence selected from the group consisting of SEQ ID NO: 1, SEQ ID NO: 3, SEQ ID NO: 5, SEQ ID NO: 7, SEQ ID NO: 9, SEQ ID NO: 11, SEQ ID NO: 13, SEQ ID NO: 15, SEQ ID NO: 17, SEQ ID NO: 19, SEQ ID NO: 21, SEQ ID NO: 23, SEQ ID NO: 25 and SEQ ID NO: 27.
7. A cyanobacterial cell according to any of the preceding claims, wherein the cyanobacterial cell is a Synechocystis, preferably a Synechocystis PCC 6803.
8. A cyanobacterial cell according to any of the preceding claims, wherein a polynucleotide encoding the at least one functional enzyme is under control of a regulatory system which responds to a change in the concentration of a nutrient when culturing said cyanobacterial cell.
9. A process for producing monoterpene comprising culturing a cyanobacterial cell according to any one of claims 1-8 under conditions conducive to the production of monoterpene and, optionally, isolating and/or purifying the monoterpene from the culture broth or headspace.
10. A process according to claim 9, wherein the culture conditions comprise feeding carbon dioxide to the culture and/or subjecting the culture to light.
11. A process according to any of claims 9 or 10 wherein the monoterpene is selected from the group consisting of: limonene, geranyl pyrophosphate, eucalyptol, pinene, menthol, camphor, linalool, γ-terpinene, Ε-β-ocimene, citral, terpineol, myrcene, citronellol, carvone and geraniol.
12. A process according to claim 11, wherein the monoterpene is limonene or linalool.
13. A monoterpene obtainable by a process according to any of claims 9 - 12.
14. A pharmaceutical composition, a fuel composition, a flavor composition, a flagrance composition or a cosmetic composition comprising a monoterpene obtainable by a process according to any of claims 9 - 12.
PCT/EP2015/066061 2014-07-14 2015-07-14 Biosynthesis of monoterpenes in cyanobacteria WO2016008883A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP14176893 2014-07-14
EP14176893.7 2014-07-14

Publications (1)

Publication Number Publication Date
WO2016008883A1 true WO2016008883A1 (en) 2016-01-21

Family

ID=51176227

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/066061 WO2016008883A1 (en) 2014-07-14 2015-07-14 Biosynthesis of monoterpenes in cyanobacteria

Country Status (1)

Country Link
WO (1) WO2016008883A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3036335A4 (en) * 2013-08-22 2017-08-30 Kiverdi, Inc. Microorganisms for biosynthesis of limonene on gaseous substrates
CN107937431A (en) * 2017-10-28 2018-04-20 国际竹藤中心 A kind of method for improving saccharomyces cerevisiae synthesis linalool ability
WO2018069418A3 (en) * 2016-10-11 2018-05-24 Evolva Sa Production of citronellal and citronellol in recombinant hosts
WO2019126778A1 (en) 2017-12-21 2019-06-27 Zymergen Inc. Nepetalactol oxidoreductases, nepetalactol synthases, and microbes capable of producing nepetalactone
CN110699383A (en) * 2019-11-08 2020-01-17 上海市农业科学院 Method for integrating multiple copies of target gene into saccharomyces cerevisiae genome
US10662415B2 (en) 2017-12-07 2020-05-26 Zymergen Inc. Engineered biosynthetic pathways for production of (6E)-8-hydroxygeraniol by fermentation
WO2020152342A1 (en) 2019-01-24 2020-07-30 Photanol B.V. A process for the bioproduction of glycolate
US11981945B2 (en) 2017-01-31 2024-05-14 C3 Biotechnologies Limited Process of producing monoterpenes

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008133658A2 (en) * 2006-11-21 2008-11-06 Amyris Biotechnologies, Inc. Jet fuel compositions and methods of making and using same
WO2009036067A2 (en) * 2007-09-11 2009-03-19 Sapphire Energy Molecule production by photosynthetic organisms
WO2012116345A2 (en) * 2011-02-24 2012-08-30 South Dakota State University Genetically engineered cyanobacteria
WO2013119644A1 (en) * 2012-02-06 2013-08-15 The Regents Of The University Of California Production of beta-phellandrene using genetically engineered cyanobacteria
US20140030785A1 (en) * 2012-07-27 2014-01-30 Wisys Technology Foundation, Inc. Methods for Isoprene and Pinene Production in Cyanobacteria

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008133658A2 (en) * 2006-11-21 2008-11-06 Amyris Biotechnologies, Inc. Jet fuel compositions and methods of making and using same
WO2009036067A2 (en) * 2007-09-11 2009-03-19 Sapphire Energy Molecule production by photosynthetic organisms
WO2012116345A2 (en) * 2011-02-24 2012-08-30 South Dakota State University Genetically engineered cyanobacteria
WO2013119644A1 (en) * 2012-02-06 2013-08-15 The Regents Of The University Of California Production of beta-phellandrene using genetically engineered cyanobacteria
US20140030785A1 (en) * 2012-07-27 2014-01-30 Wisys Technology Foundation, Inc. Methods for Isoprene and Pinene Production in Cyanobacteria

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
BOHLMANN J ET AL: "MONOTERPENE SYNTHASES FROM GRAND FIR (ABIES GRANDIS) CDNA ISOLATION, CHARACTERIZATION, AND FUNCTIONAL EXPRESSION OF MYRCENE SYNTHASE, (-)-(4S)-LIMONENE SYNTHASE, AND (-)-(1S,5S)-PINENE SYNTHASE", JOURNAL OF BIOLOGICAL CHEMISTRY, vol. 272, no. 35, 29 August 1997 (1997-08-29), pages 21784 - 21792, XP000938120, ISSN: 0021-9258, DOI: 10.1074/JBC.272.35.21784 *
CARTER O A ET AL: "Monoterpene biosynthesis pathway construction in Escherichia coli", PHYTOCHEMISTRY, vol. 64, no. 2, September 2003 (2003-09-01), pages 425 - 433, XP004448658, ISSN: 0031-9422, DOI: 10.1016/S0031-9422(03)00204-8 *
FIONA K. BENTLEY ET AL: "Paradigm of Monoterpene ([beta]-phellandrene) Hydrocarbons Production via Photosynthesis in Cyanobacteria", BIOENERGY RESEARCH, vol. 6, no. 3, 19 March 2013 (2013-03-19), pages 917 - 929, XP055141411, ISSN: 1939-1234, DOI: 10.1007/s12155-013-9325-4 *
FIONA K. DAVIES ET AL: "Engineering Limonene and Bisabolene Production in Wild Type and a Glycogen-Deficient Mutant of Synechococcus sp. PCC 7002", FRONTIERS IN BIOENGINEERING AND BIOTECHNOLOGY, vol. 2, 19 June 2014 (2014-06-19), XP055211936, DOI: 10.3389/fbioe.2014.00021 *
HOCKELMANN C ET AL: "Volatile organic compound (VOC) analysis and sources of limonene, cyclohexanone and straight chain aldehydes in axenic cultures of Calothrix and Plectonema", WATER SCIENCE AND TECHNOLOGY, vol. 49, no. 9, 2004, pages 47 - 54, XP008172207, ISSN: 0273-1223 *
KIYOTA HIROSHI ET AL: "Engineering of cyanobacteria for the photosynthetic production of limonene from CO2", JOURNAL OF BIOTECHNOLOGY, vol. 185, 4 June 2014 (2014-06-04), pages 1 - 7, XP029044551, ISSN: 0168-1656, DOI: 10.1016/J.JBIOTEC.2014.05.025 *
LÜTTGE U ET AL.: "Progress in Botany", vol. 73, 2012, SPRINGER-VERLAG, BERLIN, ISBN: 978-3-642-22745-5, article JANSSON C: "Metabolic Engineering of Cyanobacteria for Direct Conversion of CO2 to Hydrocarbon Biofuels", pages: 81 - 93, XP008172209 *
NORIHIKO MISAWA: "Pathway engineering for functional isoprenoids", CURRENT OPINION IN BIOTECHNOLOGY, vol. 22, no. 5, 9 February 2011 (2011-02-09), pages 627 - 633, XP028303030, ISSN: 0958-1669, DOI: 10.1016/J.COPBIO.2011.01.002 *
SCHMIDT ET AL: "Cloning and characterization of two different types of geranyl diphosphate synthases from Norway spruce (Picea abies)", PHYTOCHEMISTRY, vol. 69, no. 1, 18 December 2007 (2007-12-18), pages 49 - 57, XP022392508, ISSN: 0031-9422, DOI: 10.1016/J.PHYTOCHEM.2007.06.022 *

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10179920B2 (en) 2013-08-22 2019-01-15 Kiverdi, Inc. Microorganisms for biosynthesis of limonene on gaseous substrates
EP3036335A4 (en) * 2013-08-22 2017-08-30 Kiverdi, Inc. Microorganisms for biosynthesis of limonene on gaseous substrates
JP7105783B2 (en) 2016-10-11 2022-07-25 高砂香料工業株式会社 Production of citronellal and citronellol in recombinant hosts
WO2018069418A3 (en) * 2016-10-11 2018-05-24 Evolva Sa Production of citronellal and citronellol in recombinant hosts
JP2019530478A (en) * 2016-10-11 2019-10-24 エヴォルヴァ エスアー.Evolva Sa. Production of citronellal and citronellol in recombinant hosts
US11299717B2 (en) 2016-10-11 2022-04-12 Evolva Sa Production of citronellal and citronellol in recombinant hosts
US11981945B2 (en) 2017-01-31 2024-05-14 C3 Biotechnologies Limited Process of producing monoterpenes
CN107937431A (en) * 2017-10-28 2018-04-20 国际竹藤中心 A kind of method for improving saccharomyces cerevisiae synthesis linalool ability
US10662415B2 (en) 2017-12-07 2020-05-26 Zymergen Inc. Engineered biosynthetic pathways for production of (6E)-8-hydroxygeraniol by fermentation
WO2019126778A1 (en) 2017-12-21 2019-06-27 Zymergen Inc. Nepetalactol oxidoreductases, nepetalactol synthases, and microbes capable of producing nepetalactone
US10696991B2 (en) 2017-12-21 2020-06-30 Zymergen Inc. Nepetalactol oxidoreductases, nepetalactol synthases, and microbes capable of producing nepetalactone
US11193150B2 (en) 2017-12-21 2021-12-07 Zymergen Inc. Nepetalactol oxidoreductases, nepetalactol synthases, and microbes capable of producing nepetalactone
WO2020152342A1 (en) 2019-01-24 2020-07-30 Photanol B.V. A process for the bioproduction of glycolate
CN110699383A (en) * 2019-11-08 2020-01-17 上海市农业科学院 Method for integrating multiple copies of target gene into saccharomyces cerevisiae genome

Similar Documents

Publication Publication Date Title
WO2016008883A1 (en) Biosynthesis of monoterpenes in cyanobacteria
Lauersen et al. Efficient phototrophic production of a high-value sesquiterpenoid from the eukaryotic microalga Chlamydomonas reinhardtii
Wichmann et al. Tailored carbon partitioning for phototrophic production of (E)-α-bisabolene from the green microalga Chlamydomonas reinhardtii
WO2016008885A1 (en) Biosynthesis of sesquiterpenes in cyanobacteria
Davies et al. Engineering limonene and bisabolene production in wild type and a glycogen-deficient mutant of Synechococcus sp. PCC 7002
Li et al. Enhanced CO 2 capture for photosynthetic lycopene production in engineered Rhodopseudomonas palustris, a purple nonsulfur bacterium
JP7105783B2 (en) Production of citronellal and citronellol in recombinant hosts
Huang et al. Variation of herbivore-induced volatile terpenes among Arabidopsis ecotypes depends on allelic differences and subcellular targeting of two terpene synthases, TPS02 and TPS03
ES2386359T3 (en) Genetically modified host cells and use thereof to produce isoprenoid compounds
Köllner et al. Molecular and biochemical evolution of maize terpene synthase 10, an enzyme of indirect defense
EP2513303B1 (en) Valencene synthase
DK2630157T3 (en) 1-DEOXY-D-XYLULOSE 5-PHOSPHATE SYNTHASE ALLOCALLY RESPONSIBLE FOR IMPROVED TERPEN BIOSYNTHESIS
Jiang et al. A “push-pull-restrain” strategy to improve citronellol production in Saccharomyces cerevisiae
JP2018507698A (en) De novo microbial synthesis of terpenes
Han et al. Improving lipid productivity by engineering a control-knob gene in the oleaginous microalga Nannochloropsis oceanica
JP6562950B2 (en) Dreamenol synthase and method for producing dreammenol
US11767533B2 (en) Compositions and methods for production of myrcene
US20190194671A1 (en) Erythritol production in cyanobacteria
JP6622220B2 (en) Dreamenol synthase and method for producing dreammenol
WO2014092562A1 (en) Synthesis of acetoin, 2,3-butanediol and 2-butanol by cyanobacteria by heterologous expression of a catabolic pathway
CN110582568A (en) Sesquiterpene synthases for the production of drimenol and mixtures thereof
JP6748108B2 (en) Production of aromatic compounds
KR20210047992A (en) Transformed methanotrophs for producing a-humulene production from methane and uses thereof
Marmulla The anaerobic linalool metabolism in the betaproteobacteria Castellaniella defragrans 65Phen and Thauera linaloolentis 47Lol
Brown et al. Metabolic engineering of Neurospora crassa for increasing carotenoids synthesis

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15736291

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15736291

Country of ref document: EP

Kind code of ref document: A1